Agreement Preamble. Ancillary Agreements Section 4.4(a) Associate Section 8.11 Business Recitals CFC Section 4.17(f) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(f) Company Preamble Company Intellectual Property Section 4.8(a) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)
Appears in 2 contracts
Samples: Series D Preferred Share Purchase Agreement (Itui International Inc.), Series D Preferred Share Purchase Agreement (Xiaomi Ventures LTD)
Agreement Preamble. Ancillary Agreements Aggregate Consideration Section 4.4(a1.6(c) Associate Aggregate Consideration Per Share Section 8.11 Business Recitals CFC 1.6(c) beneficial owner Section 4.17(f8.4(b) Book-Entry Shares Section 1.10(b) business day Section 8.4(c) Canadian Company Sale Section 6.2(d) Canadian Plan Section 2.12(a) Cash Designated Shares Section 1.9(e)(ii)(B) Cash Election Shares Section 1.9(b) Certificate of Merger Section 1.2 Certificates Section 1.10(b) Change in the Company Recommendation Section 5.3(b) Closing Section 3.1 1.2 Closing Date Section 3.1 1.2 Code Section 4.17(f) Recitals Company Preamble Company Intellectual Property 401(k) Plan Section 4.8(a2.12(a) Company Owned Intellectual Property Benefit Plans Section 4.8(b2.12(f) Consideration Shares Company Board of Directors Section 2.2 Constitutional Documents 2.4(d) Company Common Stock Recitals Company Employees Section 4.4(a2.18 Company Employee Benefit Plans Section 2.12(c) Conversion Shares Company ERISA affiliate Section 2.5 Disclosure Schedule 2.12(a) Company Financial Advisors Section 4 Domestic 2.4(d) Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 2.1 Company Material Contract Contracts Section 4.9 OFAC 2.21(a) Company Material Subsidiaries Section 4.18(a2.1 Company Pension Plan Section 2.12(a) OFAC Sanctions Company Permits Section 4.18(a2.6(c) OFAC Sanctioned Person Company Preferred Stock Section 4.18(b2.3 Company Recommendation Section 5.1(e) Ordinary Company Reserve Reports Section 2.14(c) Company Rights Plan Section 2.3 Company Schedule Article III Company SEC Reports Section 2.7(a) Company Stockholder Approval Section 5.1(e) Company Termination Fee Section 7.3(a) Confidentiality Agreement Section 5.2(b) control Section 8.4(d) Defined Term Section or Exhibit controlled by Section 8.4(d) Debt Financing Section 5.10(a) Deemed Shares Outstanding Section 1.6(c) Delaware Law Recitals Dissenting Share Section 1.8(a) Effective Time Section 1.2 Election Deadline Section 1.9(b) Election Form Section 1.9(a) Election Form Record Date Section 1.9(a) Employment Agreement Section 4.1(f) Environmental Laws Section 2.17(a) ERISA Section 2.12(a) Exchange Act Section 2.5(b) Exchange Agent Section 1.10(a) Exchange Fund Section 1.10(a) Exchange Ratio Section 1.6(c) Expenses Section 7.3(d) Final Parent Stock Price Section 1.6(c) Funds Section 5.10(a) GAAP Section 2.1 good and defensible title Section 2.14(e) governmental authority Section 8.4(e) Hazardous Substance Section 2.17(a) HSR Act Section 2.5(b) Hydrocarbons Section 2.14(b) Indemnified Parties Section 5.4(b) Intellectual Property Section 2.20 IRS Section 2.12(a) Letter Section 3.23 Mailing Date Section 1.9(a) Merger Recitals Merger Consideration Section 1.6(a) Merger Sub Preamble NCOC 401(k) Section 2.12(a) NCOC MP Plan Section 2.12(a) Non-Election Shares Section 2.5 Personal Information 1.9(b) Notice of Intended Change in the Company Recommendation Section 4.30 PFIC 5.3(b) Oil and Gas Properties Section 4.17(g2.14(b) Public Software Option Section 4.8(g1.7(a) Purchased Outside Date Section 7.1(b)(i) Parent Preamble Parent 401(k) Plan Section 3.12(a) Parent Benefit Plans Section 3.12(f) Parent Board of Directors Section 3.4(d) Parent Common Stock Section 3.3 Defined Term Section or Exhibit Parent Employee Benefit Plans Section 3.12(c) Parent Employees Section 3.18 Parent ERISA affiliate Section 3.12(a) Parent Financial Advisor Section 3.4(d) Parent Material Adverse Effect Section 3.1 Parent Material Subsidiaries Section 3.1 Parent Parties Preamble Parent Permits Section 3.6(c) Parent Preferred Stock Section 3.3 Parent Reserve Reports Section 3.14(c) Parent Schedule Article III Parent SEC Reports Section 3.7(a) Parent Stockholder Approval Section 5.1(f) Parent Stockholders Meeting Section 5.1(f) Per Share Cash Consideration Section 1.6(c) PBGC Section 2.12(h) Per Share Stock Consideration Section 1.6(c) person Section 8.4(f) Proxy Statement/Prospectus Section 2.13 reasonable best efforts Section 8.4(g) Registration Statement Section 2.13 Restricted Shares Section 2.1 Restriction Period 1.7(b) Returns Section 8.11 Restricted Share Agreement 2.16(a) Rights Section 6.1(f2.3 Rule 145 Section 5.14(a) SDN List Xxxxxxxx-Xxxxx Act Section 4.18(b2.8(a) Secretary SEC Section 4.18(a1.10(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Securities Act Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b2.5(b)
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Plains Exploration & Production Co), Agreement and Plan of Merger (Pogo Producing Co)
Agreement Preamble. Ancillary Alliance Manager Section 3.3(a) Arbitral Decision Section 14.2(b) Claims Section 12.1 Clinical Agreement Section 5.4 Commercialization Plan Section 6.2 Common Stock Section 8.3 Company Preamble CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH THREE ASTERISKS (***), HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Definition Reference Company Board Section 11.6(c) Company Development Activities Section 5.4 Company Development Expenses Section 5.7(a) Company Indemnitees Section 12.1 Confidential Information Section 11.1 Co-Promotion Agreement Section 6.6 Co-Promotion Right Section 6.6 DoJ Section 16.19(a) Effective Date Section 14.1 Exchange Act Section 11.4(c) Execution Date Preamble Existing Inventory Section 7.3(a) Existing Regulatory Documentation Section 13.2(k) Existing Study Section 5.3(a) Facility Section 7.1(b) First Indications Section 5.3(a) FTC Section 16.19(a) Generic Market Data Section 8.7(c)(i(3) HSR Conditions Section 16.19(b) IMMU-132 Information Section 11.1 Indemnitee Section 12.3 Indemnitor Section 12.3 JCC Section 3.2 JDC Section 3.2 Joint Inventions Section 10.1 Joint Patents Section 10.3(c) JPC Section 3.2 JSC Section 3.1(a) Legal Proceeding Section 16.20 Letter Agreement Section 16.6 Licensee Preamble Licensee Indemnitees Section 12.2 Licensee Xxxx(s) Section 14.5(d) Losses Section 12.1 Manufacturing Agreements Section 4.4(a7.3(d) Associate Marks Section 8.11 Business Recitals CFC 10.8(a) Match Period Section 4.17(f11.6(b) Closing Milestone Event Section 3.1 Closing 8.4 New Affiliate Date Section 3.1 Code 2.11 No-Shop Start Date Section 4.17(f11.6(a) Company NSCLC Section 5.3(a) Other Licensed Molecule Section 2.10 Other Royalty Term Section 8.7(b)(ii) CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH THREE ASTERISKS (***), HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Definition Reference Parties Preamble Company Intellectual Property Party Preamble Product Infringement Section 4.8(a10.4(a) Company Owned Intellectual Property Publication Section 4.8(b) Consideration 11.5 Purchased Shares Section 2.2 Constitutional Documents 8.3 Qualifying Sublicensee Section 4.4(a8.2(a) Conversion Shares Reimbursable Costs Section 2.5 Disclosure Schedule 16.20 ROFN Election Notice Section 4 Domestic Company Preamble Equity Value 2.9 ROFN Notice Section 2.9 ROFN Product Section 2.9 Sale of the Company Proposal Section 2.3(i11.6(c) FCPA SCLC Section 4.19 HKIAC 5.3(a) Sole Inventions Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)10.1
Appears in 2 contracts
Samples: Development and License Agreement (Immunomedics Inc), Development and License Agreement (Immunomedics Inc)
Agreement Preamble. Ancillary Agreements Allocation Section 4.4(a2.9 Assumed Contracts Section 2.1(e) Associate Assumed Liabilities Section 8.11 2.3 Benefit Plans Section 3.1(i) Business Recitals CFC Buyer Preamble Buyer Benefit Plan Section 4.17(f4.3(a)(iv) Closing Buyer Indemnified Parties Section 3.1 8.1(b) Closing Date Section 3.1 Code 2.8 Competitive Activities Section 4.17(f4.1(c)(i) Company Preamble Company Confidentiality Agreement Section 4.2(a)(i) Consent Period Section 2.5(b) Conveyed Assets Section 2.1 Conveyed Intellectual Property Section 4.8(a2.1(c) Company Owned Damage Threshold Section 8.1(h)(i) Damages Section 8.1(b) Effective Time Section 2.8 25880894.16.BUSINESS5. Equitable Principles Section 3.1(b) Excluded Assets Section 2.2 Excluded Liabilities Section 2.4 FFDCA Section 3.1(u)(ii) Financial Statements Section 3.1(p) Healthcare Compliance Date Section 3.1(u)(i) Healthcare Permits Section 3.1(u)(i) Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii2.1(c) Material Adverse Effect Customers Section 4.1 3.1(n) Material Contract Permits Section 4.9 OFAC 3.1(k) Material Suppliers Section 4.18(a3.1(n) OFAC Sanctions Outside Date Section 4.18(a7.1(b) OFAC Sanctioned Post-Closing Dividable Contracts Section 2.6(b) Rebate Obligations Section 3.1(t)(ii) Related Person Section 4.18(b3.1(y) Ordinary Shares Required Consent Contracts Section 2.5 Personal Information 2.5(a) Restricted Territory Section 4.30 PFIC 4.1(c)(i) Seller Preamble Seller Indemnified Parties Section 4.17(g8.1(c) Public Software Statement of Net Assets Section 4.8(g3.1(p) Purchased Shares Statements of Net Sales Section 2.1 Restriction 3.1(p) Survival Period Section 8.11 Restricted Share Agreement 8.1(a) Transferrable Material Permits Section 6.1(f2.1(h) SDN List Transferred Computer Data Section 4.18(b2.1(g) Secretary Transferred Inventory Section 4.18(a2.1(a) Series D Investor(sTransferred Personal Property Section 2.1(f) Recitals Series D Preferred Shares Recitals Series D Special Redemption U.S. FDA Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b3.1(u)(ii) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Article II PURCHASE AND SALE OF CONVEYED ASSETS, ASSUMPTION OF ASSUMED LIABILITIES; CLOSING
Appears in 1 contract
Samples: Asset Purchase Agreement (Orasure Technologies Inc)
Agreement Preamble. Ancillary Agreements Balance Sheet Date Section 4.4(a3.6(a) Associate Book-Entry Shares Section 8.11 Business Recitals CFC 2.4(a) Certificates Section 4.17(f2.4(a) Chosen Courts Section 9.8 Closing Section 3.1 1.3 Closing Date Section 3.1 Code 1.3 COBRA Section 4.17(f3.9(c) Communications Laws Section 3.27 Company Preamble Company Intellectual Property Adverse Recommendation Change Section 4.8(a6.4(e) Company Owned Intellectual Property Balance Sheet Section 4.8(b3.6(a) Consideration Shares Company Board Recommendation Section 2.2 Constitutional Documents 6.2(b) Company Board Recommendation Notice Section 4.4(a6.4(g) Conversion Shares Section 2.5 Company Disclosure Schedule Section 4 Domestic 9.12 Company Preamble Equity Value of the Disqualified Persons Section 6.12(d) Company Employees Section 2.3(i6.12(a) FCPA Company Employee Plan Section 4.19 HKIAC 3.9(a) Company ERISA Affiliate Section 9.17(b3.9(a) HK Subsidiary Preamble Indemnitee Term Section 9.1(aCompany Financial Statements Section 3.6(a) Indemnifiable Loss Company Government Contract Section 9.1(a3.12(c) Investor Preamble Investor’s Partners Company Insiders Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 6.14 Company Material Contract Section 4.9 OFAC 3.12(a) Company Permits Section 4.18(a3.4(b) OFAC Sanctions Company SEC Reports Section 4.18(a3.5(a) OFAC Sanctioned Person Company Shareholder Approval Section 4.18(b3.3(b) Ordinary Company Shareholder Meeting Section 6.2(a) Company Voting Debt Section 3.2(g) Company Warrant Section 2.6(b) Confidential Information Section 3.15(j) Confidentiality Agreement Section 6.6(a) Department of State Section 1.4 Effective Time Section 1.4 Environmental Law Section 3.13 ERISA Section 3.9(a) Exchange Agent Section 2.4(a) Exchange Ratio Section 2.1(a) Excluded Shares Section 2.5 Personal Information 2.1(b) HSR Condition Section 4.30 PFIC 7.1(f) Indemnified Parties Section 4.17(g6.13(a) Public Software Insurance Policies Section 4.8(g3.17 In-the-Money Option Section 2.6(a) Purchased Shares In-the-Money SAR Section 2.1 Restriction 2.6(a) Leased Real Property Section 3.16(b) Legal Proceedings Condition Section 7.1(e) Measurement Date Section 4.2(a) Merger Recitals Merger Consideration Section 2.1(a) Merger Sub Preamble Merger Sub Documents Section 4.12(a) Notice Period Section 8.11 Restricted Share 6.4(h) Open Source Materials Section 3.15(k) Parent Preamble Parent Balance Sheet Section 4.7(a) Parent Disclosure Schedule Section 9.12 Parent Financial Statements Section 4.7(a) Parent Plans Section 6.12(b) Parent Reports Section 4.6(b) Parent Welfare Plan Section 6.12(b) Permitted Hires Section 5.2(vi) Premium Cap Section 6.13(b) Proxy/Prospectus Section 6.1(a) Registration Statement Section 6.1(a) Restraints Section 7.1(d) Xxxxxxxx-Xxxxx Act Section 3.5(b) Term Section SEC Condition Section 7.1(c) Statement of Merger Section 1.4 Support Agreement Recitals Surviving Corporation Recitals Termination Date Section 6.1(f8.1(b)(i) SDN List Termination Date Extension Section 4.18(b8.1(b)(i) Secretary Termination Fee Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b8.3(d) Transaction Documents Litigation Section 4.4(a) UNCITRAL Rules 6.16 USAC Section 9.16(b) United States Person 3.27 WARN Act Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b3.9(u)
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Alternative Acquisition Agreement Section 4.4(a8.2(a) Associate Appraisal Shares Section 8.11 Business Recitals CFC 3.7 Assumed Option Section 4.17(f3.10(a) Assumed PSU Section 3.10(d) Assumed RSU Section 3.10(b) BofA Xxxxxxx Xxxxx Section 4.22 Book-Entry Shares Section 3.5(c) Capitalization Date Section 4.5(a) Certificate Section 3.5(c) Certificate of Merger Section 3.3 Closing Section 3.1 Closing Date 3.2 Commitment Letters Section 3.1 Code Section 4.17(f5.6(b) Company Preamble Company Intellectual Property Board Recitals Company Board Recommendation Recitals Company Bonds Section 4.8(a8.11(d) Company Owned Intellectual Property Heads of Terms Section 4.8(b6.3 Company Indemnified Party Section 7.2(a) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC 4.21(a) Company Plan Section 4.18(a) OFAC Sanctions Company Preferred Stock Section 4.5(a) Company Related Parties Section 10.3(d) Company SEC Documents Section 4.7(a) Company Securities Section 4.5(b) Company Stock Recitals Company Subsidiary Securities Section 4.6(b) Company Termination Fee Section 10.3(a) Continuation Period Section 7.3(a) Continuing Employees Section 7.3(a) Copyrights Section 1.1 D&O Insurance Section 7.2(c) Debt Commitment Letter Section 5.6(b) Debt Financing Sources Section 5.6(b) DGCL Recitals Effective Time Section 3.3 Employee Plan Section 4.18(a) OFAC Sanctioned Person End Date Section 4.18(b10.1(b)(i) Ordinary Shares Enforceability Exceptions Section 2.5 Personal Information 4.2 Equity Commitment Letter Section 4.30 PFIC 5.6(b) Equity Financing Sources Section 4.17(g5.6(b) Public Software Exchange Agent Section 4.8(g3.8(a) Purchased Shares Exchange Fund Section 2.1 Restriction Period 3.8(a) Expiration Date Section 8.11 Restricted Share Agreement 2.2(a) Financing Sources Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b5.6(b)
Appears in 1 contract
Samples: Agreement and Plan of Merger
Agreement Preamble. Ancillary Agreements Assignment and Assumption Agreement Section 4.4(a2.7(a)(ii) Associate Assigned Contracts Section 8.11 2.1(a) Assumed Liabilities Section 2.3 Xxxx of Sale Section 2.7(a)(i) Business Recitals CFC Buyer Preamble Buyer Confidential Information Section 4.17(f5.7(a) Buyer Employee Benefit Plan Section 5.8(b) Closing Section 3.1 2.6 Closing Date Section 3.1 Code 2.6 Competing Business Section 4.17(f5.5(a) Company Preamble Company Intellectual Property Deductible Section 4.8(a9.4(a)(i) Company Owned Intellectual Property Direct Claim Section 4.8(b9.6(c) Consideration Shares Disclosure Schedule Article 3 Election to Defend Section 9.6(a) Escrow Agreement Section 2.7(a)(xi) Estimated Closing Statement Section 2.9(a) Excluded Assets Section 2.2 Constitutional Documents Excluded Liabilities Section 4.4(a2.4 Final Determination Section 9.8(a) Conversion Shares Final Purchase Price Section 2.5 Disclosure Schedule 2.9(c)(ii) Financial Statements Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i3.4(a) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee General Survival Date Section 9.1(a) Indemnifiable Loss Illustrative NWC Calculation Section 9.1(a1.1 Indemnified Party Section 9.6(a) Investor Preamble Investor’s Partners Indemnitor Section 8.17(b9.6(a) Key Employee Insurance Policies Section 4.22 Key Holders Preamble Lease 3.21(a) International Trade Laws and Regulations Section 4.7(b3.22 IP Assignment Agreement Section 2.7(a)(iii) Licenses Leased Real Property Section 4.8(e3.16(b) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC 3.15(a) Material Customer Section 4.18(a3.23(a) OFAC Sanctions Material Provider Section 4.18(a3.23(b) OFAC Sanctioned Person Objection Notice Section 4.18(b2.9(c)(i) Ordinary Shares Owned Real Properties Section 2.5 Personal 3.16(a) Purchase Price Section 2.8(a) Purchased Inventory Section 2.1(g) Real Property Lease Section 3.16(b) Response Period Section 2.9(c)(i) Seller Preamble Seller Confidential Information Section 4.30 PFIC 5.7(a) Standard Form IP Agreement Section 4.17(g3.13(b) Public Software Third-Party Claim Section 4.8(g9.6(a) Purchased Shares Third-Party Claim Notice Section 9.6(a) Title Materials Section 3.16(a) Trade Authorizations Section 3.22(a) Transfer Taxes Section 10.1 Transferred Assets Section 2.1 Restriction Period Section 8.11 Restricted Share Transition Services Agreement Section 6.1(f2.7(a)(iv) SDN List Welfare Benefits Section 4.18(b5.8(d) Secretary Closing Statement Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b2.9(b)
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Section 4.4(a) Associate Section 8.11 Business Recitals CFC Section 4.17(f) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(f) Company Preamble Company Intellectual Property Section 4.8(a) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Investors Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Preamble
Appears in 1 contract
Samples: Series D Preferred Share Purchase Agreement (Itui International Inc.)
Agreement Preamble. Ancillary Agreements Section 4.4(aApplicable Survival Period 9.1(c) Associate Section 8.11 Assigned Contracts 2.1(d) Assumption Agreement 3.2(b) Assumed Liabilities 2.3 Bxxxxxxxx Employment Agreement 3.2(g) Business Recitals CFC Section 4.17(f) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(fClosing Date Shortfall Certificate 2.7(b) Company Preamble Company Intellectual Closing Certificate 7.2(c) Confidentiality Agreement 6.2 Consideration 2.5(a) Contributed Assets 2.1 Contribution Recitals Contributor Preamble Contributor Closing Certificate 7.1(c) Copyrights 4.12(a) Deductible Amount 9.7 Disposition 5.9 Electronic Delivery 10.7 Exchange Act 5.8(a) Excluded Assets 2.2 Excluded Contracts 2.2(a) Excluded Liabilities 2.4 FINRA 5.4(b) GP Audited Financial Statements 4.4(a)(i) GP Benefit Plans 4.17(a) GP Disclosure Schedule Article IV GP Financial Statements 4.4(a)(ii) GP Interim Balance Sheet 4.4(b) GP Interim Balance Sheet Date 4.4(b) GP Interim Financial Statements 4.4(a)(ii) GP Leased Real Property Section 4.8(a4.11(a) Company GP Lock-Up Agreement 3.2(i) GP Owned Intellectual Property Section 4.8(b4.12(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(aGP Policies 4.19(a) Conversion Shares Section 2.5 GP Registered Items 4.12(d) GP Warrant 3.3(s) In-Bound Licenses 4.12(c) Indemnitee 9.4(a) Indemnitor 9.4(a) Intellectual Property 4.12(a) Intellectual Property Rights 4.12(a) JTF Lock-Up Agreement 3.2(j) Lxxxx Employment Agreement 3.2(h) Liabilities 4.5 Losses 9.2 Mxxx Employment Agreement 3.2(f) Marks 4.12(a) GP Material Contracts 4.14(b) Names 6.8 NWT Audited Financial Statements 5.10(a)(i) NWT Disclosure Schedule Section 4 Domestic Company Article V NWT Financial Statements 5.10(a)(ii) NWT Group Article V NWT Intellectual Property 5.20(a) NWT Interim Financial Statements 5.10(a)(ii) NWT Material Contracts 5.21(b) NWT Personal Property 5.17 NWT Policy 5.25(a) NWT Stock Plan 5.23(a) Notice of Claim 9.4(a) Parties Preamble Equity Value of the Company Section 2.3(iParty Preamble Patents 4.12(a) FCPA Section 4.19 HKIAC Section 9.17(bPension Plan 4.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g4.12(i) Public Personal Property 4.9(a) Privacy Policy 4.12(i) Processing 4.12(i) Prohibited Transaction 6.5(a) Proprietary Information 4.12(a) Real Property 4.13(a) Registration Rights Agreement 3.2(d) Representatives 6.2 Restricted Actions 5.26 Restricted Contract 2.6(a) SEC 4.23 SEC Reports 5.8(a) Securities Act 4.23 Software Section 4.8(g4.12(a) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(fSuper 8-K 6.14 Third Party Claim 9.4(a) SDN List Section 4.18(bThird Party Defense 9.4(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(bTransferred Employees 6.9(a)
Appears in 1 contract
Samples: Asset Contribution Agreement (GRANDPARENTS.COM, Inc.)
Agreement Preamble. Ancillary Agreements Borrowed Money Indebtedness Section 4.4(a1.04(b)(i)(A) Associate Business Entity Section 8.11 Business Recitals CFC 5.07(a) Canadian NewCo Section 4.17(f) 5.19 Closing Section 3.1 1.04(a) Closing Date Section 3.1 Code 1.04(a) Collar Amount Section 4.17(f1.05(d) Company Preamble Company Intellectual Policies Section 3.18 Company Savings Plan Section 7.02(c) NAI-1502820106v1 Term Section Confidentiality Agreement Section 5.02(a) Continuing Employees Section 7.01(b) CSP Transfer Date Section 7.02(c) CTDEEP Section 1.04(d)(xiii) D&O Costs Section 5.13(b) D&O Expenses Section 5.13(b) D&O Indemnifiable Claim Section 5.13(b) D&O Indemnified Person Section 5.13(a) D&O Indemnifying Party Section 5.13(b) Debt Payoff Recipients Section 1.04(b)(i)(A) DSS Companies Preamble ECAF Section 1.04(d)(xiii) Effective Date Preamble Employee List Section 7.01(b) Employee Plans Section 3.10(a) Employee Transfer Date Section 7.01(b) Estimated Final Working Capital Section 1.03 Excluded Employee Section 7.01(b) Financial Statements Section 3.05(a) Final Closing Statement Section 1.05 Foreign Plan Section 3.10(i) Form III Section 1.04(d)(xiii) General Enforceability Exceptions Section 2.02 HSR Clearance Section 5.06(a) Insurance Policies Section 3.18 Interim Balance Sheet Section 3.05(a) In-scope Employee Section 7.01(b) Joint Contract Section 3.19(d) Material Contracts Section 3.14(a)(xii) Parent Policies Section 3.18 Permits Section 3.09(b) PolyOne Savings Plan Section 7.02(b) Purchase and Sale Section 1.04(a) Purchase Price Section 1.02 Purchaser Preamble Purchaser Fundamental Representations Section 10.01 Purchaser Indemnified Parties Section 10.02(a) Purchaser Prepared Tax Returns Section 6.05(b) Purchaser’s Flexible Spending Account Plan Section 7.02(e) Purchaser’s Savings Plans Section 7.02(b) Purchaser Group Health Plan Section 7.02(a) NAI-1502820106v1 Term Section Real Property Section 4.8(a3.12(a) Company Owned Intellectual Property Restricted Period Section 4.8(b5.07(a) Consideration Shares Representatives Section 2.2 Constitutional Documents 5.04 Seller Preamble Seller Indemnified Parties Section 4.4(a10.03(a) Conversion Shares Seller Prepared Tax Returns Section 2.5 Disclosure Schedule 6.05(a) Seller’s Flexible Spending Account Plan Section 4 Domestic Company Preamble Equity Value of the Company 7.02(e) Seller Group Health Plan Section 2.3(i7.02(a) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Shared Contract Section 4.9 OFAC 3.19(c) Termination Date Section 4.18(a9.01(b) OFAC Sanctions Third-Party Claim Section 4.18(a10.04(a) OFAC Sanctioned Person Tradenames and Trademarks Section 4.18(b5.10(b) Ordinary Shares Transaction Accounting Principles Section 2.5 Personal Information 3.05(a) Transaction Expense Amount Section 4.30 PFIC 1.04(b)(i)(B) Transaction Expense Recipients Section 4.17(g1.04(b)(i)(B) Public Software Transfer Taxes Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share 6.04 Transition Services Agreement Section 6.1(f1.04(c)(ii) SDN List Units Preamble WARN Section 4.18(b3.11(e) Secretary WARN Act Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)5.08
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Section 4.4(aBuyer Preamble Buyer Cap 9.4(a) Associate Section 8.11 Business Recitals CFC Section 4.17(f) Claim Notice 9.5 Closing Section 3.1 Closing Date 3.1 Term Section 3.1 Code Section 4.17(fCommon Stock 4.5(a) Company DC Plan 6.8(d) Company Minority Interest 4.6(a) Company Plan 4.14(a) Company-Required IP 6.12(a) Company Subsidiary 4.6(a) Confidentiality Agreement 6.2(b) Controlling Party 9.6(a) Deductible 9.4(b) Dispute 10.11(a) Equitable Exceptions 4.2 Estimated Closing Working Capital 6.14(a) Excluded Employees 6.8(c) Extended Termination Date 8.1(b) Financing 6.3(g) financing sources 9.4(h) Indemnifiable Losses 9.4(b) Indemnified Person 9.4(c) Indemnifying Party 9.4(c) Interest Expense Carryforward Amount 4.12(l) Joint Tax Claim 9.6(a) Key Customer 4.22(a) Lease 4.16(b) Material Contracts 4.10(a)(ix) New York Courts 10.11(c) Non-Controlling Party 9.6(a) Parent Preamble Company Intellectual Property Section Pre-Closing Tax Return 6.10(c) Pre-Closing/Straddle Tax Returns 6.10(c) Pro-Rata Matching Contribution 6.8(d) Purchase Price 2.1(a) Registered IP 4.8(a) Company Owned Intellectual Property Section 4.8(bReleased Obligations 6.9 Reorganization Transactions 6.11(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(aRetained Employee Liabilities 6.8(c) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Sanctions 4.21(b) Securities Recitals Seller Preamble Equity Value of the Company Section 2.3(iSeller-Required IP 6.12(b) FCPA Section 4.19 HKIAC Section 9.17(bSellers Preamble Sellers Cap 9.4(a) HK Subsidiary Preamble Indemnitee Section 9.1(aService Provider 4.14(e) Indemnifiable Loss Section 9.1(aStraddle Tax Return 6.10(c) Investor Preamble Investor’s Partners Section 8.17(bTax Sharing Agreement 4.12(c) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(bTermination Date 8.1(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(bTermination Fee 8.3 Third-Party Claim 9.5 Working Capital Statement 6.14(a)
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Balance Sheet Section 4.4(a3.5(a) Associate Balance Sheet Date Section 8.11 Business Recitals CFC 3.5(a) Blue Sky Laws Section 4.17(f2.5 CDPH Section 3.16(c) CHOW Section 5.4(c) CLIA Application Section 5.4(c) Closing Section 3.1 (a) Closing Date Section 3.1 Code 1.2 CMS Section 4.17(f3.16(c) CMS Application Section 5.4(c) Collected Receivables Section 1.1(b) Company Preamble Company IP Rights Section 3.11(a) Company ERISA Affiliate Section 3.13(a) Company Parties Section 5.10(c) Disclosure Schedule Section 9.11 Employee Benefit Plans Section 3.13(a) Environmental Permits Section 3.17(a) ERISA Section 3.13(a) Financial Statements Section 3.5(a) HIPAA Section 3.16(a) HITECH Section 3.16(a) Indemnified Party Section 7.3(a) Indemnifying Party Section 7.3(a) Intellectual Property Licenses Section 4.8(a3.11(b) Company Leased Properties Section 3.9(b) License CHOW Application Section 5.6(c) Losses Section 7.1 Medicaid Notice Section 5.4(c) Medytox Preamble Multiemployer Plans Section 3.13(a) Multiple Employer Plans Section 3.13(a) NPI Update Section 5.4(c) Owned Intellectual Property Section 4.8(b3.11(a) Consideration Outstanding Accounts Receivable Section 1.1(b) Outstanding Payables Section 6.1(d) Party Preamble Payoff Letters Section 6.1(d) Personal Property Leases Section 3.10(a) PII Section 3.11(m) Preferred Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g1.1(b) Purchased Shares Recitals Purchaser Preamble Purchaser Indemnitees Section 2.1 Restriction 7.1 Purchaser’s Agents Section 5.2(a) Qualified Plans Section 3.13(c) Real Property Laws Section 3.9(c) Real Property Lease Section 3.9(b) Seller Preamble Series E Preferred Stock Section 1.1(b) Shares Recitals Straddle Period Section 8.11 Restricted Share Agreement 5.8(c) Systems Section 6.1(f) SDN List 3.24 Third Party Claim Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b7.3(a) Transaction Documents Consideration (b) Transactional Rep Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)7.4
Appears in 1 contract
Agreement Preamble. Ancillary Allowed Administrative Claims Payment Section 2.1(a)(vii) Allowed Priority Claims Payment Section 2.1(a)(viii) Allowed Secured Claims Payment Section 2.1(a)(vi) Assumed Contract List Section 5.16 Balance Sheet Section 3.11(a)(i) Balance Sheet Date Section 3.11(a)(i) Bankruptcy Case Recitals Bankruptcy Code Recitals Bankruptcy Court Recitals Capped Payments Section 2.1(b) Change in Control Agreements Section 4.4(a3.18(f) Associate Chapter 11 Cases Section 8.11 Business Recitals CFC 5.13 Chapter 5 Claims Section 4.17(f) 1.1 Closing Section 3.1 2.6 Closing Date Section 3.1 Code 2.6 COBRA Section 4.17(f3.18(g) Company Preamble Company Disclosure Schedule Article 3 Cure Amount Payment Section 2.1(a)(ix) Deposit Section 2.5 DIP Payment Section 2.1(a)(i) DOJ Section 5.6(b) DOL Section 3.18(c)(vii) EEOC Section 3.19(a)(xi) Electronic Copy Section 9.11(b) Employee Plan(s) Section 3.18(a)(iii) Escrow Fee Payment Section 2.1(a)(xii) Financial Statements Section 3.11(a) FIRPTA Affidavit Section 2.8(g) Term Reference FTC Section 5.6(b) Hired Employees Section 6.1(b) Indemnification Payment Section 2.1(a)(x) Intellectual Property Assignments Section 2.8(c) IRB Payment Section 2.1(a)(iii) Leased Real Property Section 3.20(b) Listed Intellectual Property Section 4.8(a3.21(b) Company Management Incentive Plan Section 6.2 Metalsa Section 5.1(b)(xiii) Name Change Filings Section 5.13 Monthly Representation Report Section 5.1(a)(v) Notice Group Section 5.2(a)(i) Owned Intellectual Real Property Section 4.8(b3.20(a) Consideration Shares Party(ies) Preamble Purchase Price Balance Section 2.2 Constitutional Documents 2.1(e) Purchase Price Cap Section 4.4(a2.1(b) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Purchaser Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Real Property Lease Section 4.7(b3.20(b) Licenses Reorganizations Section 4.8(e5.11 Second Lien Fee Claim Section 2.1(a)(ii) Second Lien Payment Section 2.1(a)(ii) Seller Preamble Seller Certificate Section 7.2(c) Senior Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii6.2 Subsequent Purchase Price Payment Section 2.1(e) Material Adverse Effect Subsequent Purchase Price Payment Notice Section 4.1 Material Contract 2.1(e) Supplier(s) Section 4.9 OFAC 3.15 Tail Payment Section 4.18(a2.1(a)(xi) OFAC Sanctions Tail Policy Section 4.18(a2.1(a)(xi) OFAC Sanctioned Person Tax-Qualified Plan Section 4.18(b3.18(h) Ordinary Shares Termination Date Section 2.5 Personal Information 8.1(c) Unsecureds Claim Payment Section 4.30 PFIC 2.1(a)(iv) Unsecureds Funds Payment Section 4.17(g2.1(a)(v) Public Software WARN Act Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b3.19(a)(i)
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Section 4.4(aApprovals 3.1(a) Associate Section 8.11 Business Recitals CFC Section 4.17(fAssumed Options 2.1(b)(ii) Assumed Plan 2.1(b)(iii) Blue Sky Laws 3.5(b) business day 9.3(b)(i) Certificate of Merger 1.2 Certificates 2.2(c) Change in Recommendation 6.2(b) Closing Section 3.1 1.2 Closing Date Section 3.1 1.2 COBRA 3.11(a)(i) Code Section 4.17(f2.2(e) Company Preamble Company 2001 Plan 2.1(b)(v)(2) Company 2001 Plan Options 2.1(b)(v)(2) Company Acquisition 8.3(b)(i) Company Balance Sheet 3.8 Company Balance Sheet Date 3.8 Company Board Recitals Company Capital Stock 2.1(f) Company Charter Documents 3.2 Company Common Stock 2.1(a) Company Contract 3.19(b) Company Disclosure Letter Article III Company Employee Plan 3.11(a)(ii) Company ESPP 2.1(c) Company Financial Advisor 3.17 Company Form 10-KSB 3.1(b) Company Indemnification Provisions 6.11(a) Company Indemnified Persons 6.11(a) Company Intellectual Property Section 4.8(a3.18(a)(ii) Company Owned Meeting 3.4(b) Company Optionholder 2.1(b)(i) Company Option Plans 2.1(b)(v)(1) Company Preferred Stock 3.3(a)(i) Company Privacy Policy 3.18(a)(viii) Company Products 3.18(a)(iii) Term Paragraph Company Registered Intellectual Property Section 4.8(b3.18(a)(iv) Consideration Company SEC Documents 3.7(a) Company Securityholders 2.2(a) Company Source Code 3.18(r) Company Stock Options 2.1(b)(i) Company Stockholders 2.2(a) Company Stockholder Approval 3.4(b) Confidentiality Agreement 6.3 Contract 3.1(b) Contractor Agreement Recitals Copyrights 3.18(a)(i) Delaware Law Recitals Dissenting Shares Section 2.2 Constitutional Documents Section 4.4(a2.3(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(iDOL 3.11(a)(iii) FCPA Section 4.19 HKIAC Section 9.17(bEffect 9.3(b)(iv) HK Subsidiary Preamble Indemnitee Section 9.1(aEffective Time 1.2 Employee 3.11(a)(iv) Indemnifiable Loss Section 9.1(aEmployee Agreement 3.11(a)(v) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Employment Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Recitals
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Buyer Preamble Buyer Disclosure Documents Section 4.4(a6.08(a) Associate Buyer Indemnified Party Section 8.11 Business Recitals CFC 8.02(a) Buyer Indemnifying Party Section 4.17(f8.02(b) Buyer Shares Section 2.02(a)(i) Buyer Sub Preamble Cash Purchase Price Accounts Section 2.02(c) Claim Section 7.05(a) Closing Section 3.1 3.01 Location of Definition Defined Term Closing Date Section 3.1 Code 3.01 Closing Payment Section 4.17(f2.02(b) Cap Section 8.06 COBRA Section 4.12(e) Company Preamble Company Intellectual Shares Recitals Damages Section 8.02(a) Disclosure Letter Article IV Environmental Law Section 4.16 ERISA Section 4.12(a) ERISA Affiliate Section 4.12(a) Expenses Section 7.04 Foreign Plans Section 4.12(k) GAAP Section 4.04(b) Governmental Entity Section 4.03(b) Hazardous Substance Section 4.16 Indemnification Escrow Section 2.05 Indemnification Escrow Agreement Section 2.05 Indemnified Party Section 8.02(b) Indemnifying Party Section 8.02(b) Indemnity Claim Section 8.03 Major Customers Section 4.20 Material Agreement Section 4.11(a) Notice Section 8.03 Objection Notice Section 8.05(a) Permits Section 4.07(a) Purchase Price Section 2.02(b) Real Property Section 4.8(a4.14(a) Company Owned Intellectual Property Release Section 4.8(b7.05(a) Consideration Shares Release Date Section 2.2 Constitutional Documents 2.05 Releasors Section 4.4(a7.05(a) Conversion Shares Released Claims Section 2.5 Disclosure Schedule 7.05(b) Releasees Section 4 Domestic Company 7.05(a) Restricted Stock Section 280G Cap Section 2.04 Restricted Stock Total Payment Section 2.04 Sellers Preamble Equity Value of the Company Seller Common Stock Section 2.3(i4.02 Seller Indemnifying Party Section 8.02(a) FCPA Seller Preferred Stock Section 4.19 HKIAC 4.02 Sellers’ Representative Section 9.17(b8.08(a) HK Subsidiary Preamble Indemnitee Standard IP Agreements Section 9.1(a4.11(a)(x) Indemnifiable Loss Stock Option Section 9.1(a280G Cap Section 2.03(c) Investor Preamble Investor’s Partners Stock Option Total Payment Section 8.17(b2.03(c) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Survival Period Section 8.11 Restricted Share Agreement 8.01 Termination Provisions Section 6.1(f7.07(b) SDN List Location of Definition Defined Term Third-Party Claim Section 4.18(b) Secretary 8.04 Threshold Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption 8.06 Violation Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b4.03(c)
Appears in 1 contract
Samples: Stock Purchase Agreement (Complete Production Services, Inc.)
Agreement Preamble. Ancillary Agreements Amended and Restated Indenture Section 4.4(a1.1(c) Associate Articles Section 8.11 Business 2.2 business day Section 8.3(a) Cash-Paid Notes Tender Offer Recitals CFC Cash-Paid Notes Tender Offer Conditions Section 4.17(f1.2(a) Cash-Paid Notes Tender Offer Documents Section 1.2(b) Closing Section 3.1 1.6 Closing Date Section 3.1 1.6 Code Section 4.17(f2.10(a)(iii) collective bargaining agreement Section 8.3(a) Company Preamble Company Intellectual Property Disclosure Schedule ARTICLE II Company Employees Section 4.8(a2.10(c)(i) Company Owned Intellectual Property Plan Section 4.8(b2.10(c)(i) Consideration Shares Company Shareholder Approval Section 6.1(c) Company Shareholder Meeting Section 5.1(a) Company Warrants Section 2.3(a) Confidentiality Agreement Section 5.2(b) Consent Solicitation Recitals Contract Section 2.5(a) control Section 8.3(a) controlled Section 8.3(a) Term Section controlled by Section 8.3(a) Dataroom Section 2.2 Constitutional Documents Debt Purchaser Preamble Deutsche Bank Section 4.4(a5.1(a) Conversion Shares Equity Financing Section 2.5 Disclosure Schedule 3.7(a) Equity Financing Commitment Section 4 Domestic Company 3.7(a) Equity Purchaser Recitals ERISA Section 2.10(c)(i) ERISA Affiliate Section 2.10(c)(ii) Exchange Act Section 2.5(b) executive officer Section 8.3(a) Financing Section 3.7(a) Financing Commitments Section 3.7(a) Foreign Antitrust Laws Section 2.5(b) Fund Section 3.7(a) generally accepted accounting principles Section 8.3(a) Governmental Entity Section 2.5(b) HTCC Preamble Equity Value of the Company HTCC Sub Recitals Hungarian Telecom Section 2.3(i3.7(a) FCPA IRS Section 4.19 HKIAC 2.10(a)(iii) knowledge Section 9.17(b8.3(a) HK Subsidiary Preamble Indemnitee Law Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b2.5(a) Licenses Section 4.8(e2.6(b) Management Founder Lien Section 2.3(a) Magyar Telecom Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 2.1 Material Contract Section 4.9 OFAC 2.12(a) Memorandum of Incorporation Section 4.18(a2.2 MEP Section 3.1 New Shareholder Loan Section 1.4(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share New Shareholder Loan Agreement Section 6.1(f1.4(a) SDN List Notice Section 4.18(b5.1(b) Secretary Term Section 4.18(aOrder Section 2.5(a) Series D Investor(sperson Section 8.3(a) PIK Notes Tender Offer Recitals Series D Preferred PIK Notes Tender Offer Conditions Section 1.1(a) PIK Notes Tender Offer Documents Section 1.1(d) Proposed Amendments Section 1.1(c) Purchaser Directors Section 5.1(a) Purchasers Recitals Regulations S Section 8.3(a) Regulatory Requirements Section 2.5(b) Requisite Noteholder Consents Section 1.1(c) Roll-Over Section 3.7(a) Roll-Over Commitments Section 3.7(a) Sxxxxxxx-Xxxxx Act Section 2.7(c) SEC Section 2.7(a) SEC Reports Section 2.7(a) Securities Act Section 2.7(a) Senior Facilities Agreement Annex 1.5 Seller Loan Agreement Recitals Shares Recitals Series D Special Redemption Subordinated Loan Agreement Annex 1.5 Subordinated Term Loan Recitals subsidiaries Section 8.24 Series D Special Redemption Shareholder 8.3(a) subsidiary Section 8.24 Special Redemption Consideration Shares 8.3(a) Tag Along Agreement Section 8.24 Special Redemption Price 2.20 Tax Return Section 8.24 Subpart F Income 2.14(b) Taxes Section 8.17(b2.14(b) Transaction TDC Recitals TDC Agreement Recitals TDC Documents Section 4.4(a5.9 Termination Date Section 7.1(c) UNCITRAL Rules Trustee Section 9.16(b1.1(c) United States Person under common control with Section 4.18(c8.3(a) WFOE Preamble Xunlei Group U.S. Section 8.5(b)2.5(b) Term Section Voting Agreement Section 3.7(b) 2004 Notes Recitals 2006 PIK Notes Recitals 2006 PIK Notes Indenture Recitals 2007 Notes Recitals
Appears in 1 contract
Samples: Debt Restructuring Agreement (Hungarian Telecom LP)
Agreement Preamble. Ancillary Agreements Allocation Statement Section 4.4(a) Associate 2.07 Apportioned Tax Obligations Section 8.11 8.01 Assignment and Assumption Agreement Section 2.08 Assumed Liabilities Section 2.03 Business Recitals CFC Business Leases Section 4.17(f) 3.11 8 Term Section Buyer Preamble Buyer Indemnified Parties Section 11.02 Cash Consideration Section 2.07 Change Section 7.05 Closing Section 3.1 2.08 Closing Date Statement of Assets and Liabilities Section 3.1 Code Section 4.17(f2.10(a) Common Stock Recitals Company Preamble Company Benefit Plans Section 9.04 Contracts Section 2.01 Copyright Assignment Agreement Section 2.08 Customer Information Section 3.16 Damages Section 11.02 Debt Consideration Section 2.07 Delayed Assets Section 2.01(c) Delayed Assets Assignment and Assumption Agreement Section 2.09 Delayed Closing Section 2.09 Domain Name Transfer Agreement Section 2.08 Excluded Assets Section 2.02 Excluded Employees Section 9.02 Excluded Liabilities Section 2.04 Excluded Licenses Section 2.02 FDA Section 3.10 Field Section 5.03 Final Working Capital Section 2.11 Indemnified Party Section 11.03 Indemnifying Party Section 11.03 Intellectual Property License Agreement Section 4.8(a) Company Owned 2.08 Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei 3.15 Inventory Section 2.3(ii) 2.01 Material Adverse Effect Contracts Section 4.1 3.08 Material Contract Distributors Section 4.9 OFAC 3.22 Material Suppliers Section 4.18(a) OFAC Sanctions 3.22 Opt-out Notifications Section 4.18(a) OFAC Sanctioned Person 3.16 Outbound Intellectual Property Licenses Section 4.18(b) Ordinary Shares 3.15 Patent Assignment Agreement Section 2.5 Personal Information 2.08 Permitted Liens Section 4.30 PFIC 3.11 Xxxxx Cash Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction 2.01 Post-Closing Tax Period Section 8.11 Restricted Share Agreement 8.01 Potential Contributor Section 6.1(f11.05(e) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Stock Recitals
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Section 4.4(aBright House Partnership Agreement 6.06 Burdensome Condition 8.01(e) Associate Section 8.11 Business Recitals CFC Section 4.17(fCertificates 2.03(a)(ii) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(f2.01(b) Company Preamble Company Intellectual Property Section 4.8(aAdjusted Option 2.04(a) Company Owned Intellectual Property Section 4.8(bAdjusted RSU 2.04(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(aCompany Board Recommendation 4.02(b) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value Certificate of the Merger 2.01(c) Company Section 2.3(iCertificates 2.03(a)(ii) FCPA Section 4.19 HKIAC Section 9.17(bCompany International Plan 4.17(i) HK Subsidiary Preamble Indemnitee Section 9.1(aCompany Investment 4.06(c) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Company Material Contract 4.19(a)(ix) Company Merger Consideration 2.02(a)(i) Company Mergers 2.01(a)(iii) Company Option A Cash Consideration 2.02(a)(i) Company Option A Merger Consideration 2.02(a)(i) Company Option A Stock Consideration 2.02(a)(i) Company Option B Cash Consideration 2.02(a)(i) Company Option B Merger Consideration 2.02(a)(i) Company Option B Stock Consideration 2.02(a)(i) Company Plans 4.17 Company Preferred Stock 4.05 Company Related Parties 10.02(h) Company RSU 2.04(b) Company SEC Documents 4.07 Company Securities 4.05(b) Company Stock Option 2.04(a) Company Stockholder Approval 4.02 Company Stockholder Meeting 6.02 Company Subsidiary Securities 4.06(b) Company Superior Proposal 6.03(e) Company Surviving Corporation 2.01(a)(ii) Term Section 4.9 OFAC Company Termination Fee 10.02(e) Company Transaction Litigation 8.10 Company Uncertificated Shares 2.03(a)(ii) Confidentiality Agreement 6.03(b)(i) Consolidated Group Recitals Continuation Period 7.09 Continuing Employee 7.09 D&O Insurance 7.07(c) Debt Commitment Letter 5.21 Debt Financing 5.21 DGCL Recitals Director 2.04(c) Director RSU 2.04(c) Dissenting Shares 2.10(a) Effective Time 2.01(d) Election 2.02(a)(i) Election Deadline 2.03(a)(iv) Election Form 2.03(a)(i) Election Form Record Date 2.03(a)(iii) Employee Communication Strategy 7.09(g) End Date 10.01(b)(i) Exchange Agent 2.03(a)(ii) Exchange Fund 2.03(a)(v) Financing Related Parties 10.02(h) First Company Merger 2.01(a)(ii) First Company Merger Effective Time 2.01(d) Former Employee 2.04(d) Former Employee Option 2.04(d) Former Employee RSU 2.04(d)(ii) Indemnified Person 7.07 Intended Tax Treatment Recitals Joint Proxy Statement/Prospectus 4.09 Lease 4.14(b) Liberty Broadband Recitals Mailing Date 2.03(a)(iii) Merger Communication 8.03(b) Merger Sub One Securities 5.05(b) Merger Sub Two and Three Securities 5.05(b) Merger Subsidiary One Preamble Merger Subsidiary Three Preamble Merger Subsidiary Two Preamble Merger Subsidiary Two Certificate of Merger 2.01(c) Merger Subsidiary Two Surviving Entity 2.01(a)(iii) Mergers 2.01(a)(iv) Multiemployer Plan 4.17(c) Term Section 4.18(aNew Charter Merger Consideration 2.02(b)(i) OFAC Sanctions New Charter Plans 7.09(d) New Charter Stock Issuance 7.03 Notional Adjusted Option 2.04(d) Notional Adjusted RSU 2.04(c) NYSE 4.03 Parent Preamble Parent Adjusted Option 2.05 Parent Adjusted RSU 2.05(c) Parent Adjusted Stock Award 2.05(b) Parent Board Recommendation 5.02(b) Parent Certificate of Merger 2.01(c) Parent Certificates 2.03(a)(ii) Parent Merger 2.01(a)(iv) Parent Merger Consideration 2.02(c)(i) Parent Merger Effective Time 2.01(d) Parent Plans 5.15(a) Parent Preferred Stock 5.05 Parent Regulatory Termination Fee 10.02(d) Parent RSU 2.05(c) Parent SEC Documents 5.07 Parent Securities 5.05(b) Parent Stock Award 2.05(b) Parent Stock Option 2.05 Parent Stockholder Approval 5.02 Parent Stockholder Meeting 7.03 Parent Subsidiary Securities 5.06(b) Parent Superior Proposal 7.04(e) Parent Surviving Entity 2.01(a)(iv) Parent Termination Fee 10.02(b) Parent Transaction Litigation 8.10 Parent Uncertificated Shares 2.03(a)(ii) Redemption Recitals Registration Statement 4.09 reportable transaction 5.14(e) Representatives 6.03(a) Represented Employee 7.09 Required Payment Amount 5.21 Second Company Merger 2.01(a)(iii) Second Company Merger Effective Time 2.01(d) Significant Subsidiary 4.06 Specified Company SEC Documents Article 4 Specified Parent SEC Documents Article 5 Title IV Plan 4.17(b) TWX 4.16(b) Term Section 4.18(aUncertificated Shares 2.03(a)(ii) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Voting Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Recitals
Appears in 1 contract
Samples: Agreement and Plan of Mergers (Time Warner Cable Inc.)
Agreement Preamble. Ancillary Alliance Manager 3.1 Assumed Development Activities 4.3.1 Bankruptcy Code 12.8 Biohaven Preamble Biohaven BMS Non-Compete Term 5.7.1(b) Biohaven HoldCo Preamble Biohaven Ireland Preamble Biohaven Patent Stepdown 6.5.2 Biohaven Patent Stepdown Amount 6.6.4 BioShin Preamble BioShin Additional Third Party License 14.5.1 BioShin Patent Stepdown 14.4.2 BioShin Royalty Term 14.4.1 BioShin Territory Biohaven Patent Stepdown Amount 14.5.4 BMS Definition of “BMS Agreement” Defined Term Section BMS Consent Letter Recitals BMS Sublicense Recitals Chosen Court 13.3 CMC Strategy 3.3.2(c) Commercialization Plan 5.2.1 Competitive Activities 5.7.2(d) CRLR Definition of “CGRP Receptor” Development Activities Cure Period 4.3.1 Development Plan 4.2.1 Disclosing Party 8.1 Discontinuation Notice 4.3.1 Distribution Agreement 5.5.3(c) Educational Materials 5.4 Execution Date Preamble Global Safety Database 4.8 Indemnification Claim 10.3 Indemnitee 10.3 Indemnitor 10.3 Independent Affiliate 5.7.2(d) Initial Commercialization Plan 5.2.1 Initial Development Plan 4.2.1 Inventions 7.1.1 JCC 3.4.1 JDMRC 3.2.1 JMC 3.3.1 Joint Inventions 7.1.2 Joint Patent Rights 7.3 Licensor Preamble Licensor Company Marks 7.6.3 Licensor Product Marks 7.6.3 Losses and Claims 10.1 Defined Term Section Marketing Materials 5.4 material adverse condition or event 4.7 Modified Clause 13.11 NICE Appraisal 6.3 Notice of Dispute 13.2.1 Notice Period 12.3.2 OTC Nurtec 6.8 Party Preamble Party Vote 3.7 Pfizer Preamble Pfizer BMS Non-Compete Term 5.7.1 Pfizer Development Activities 4.2.3 Pfizer Product Marks 7.6.2 Prevention Indication Definition of “Initial Indications” Quality Agreements 5.5.3(b) RAMP 1 Definition of “CGRP Receptor” RCP Definition of “CGRP Receptor” Receiving Party 8.1 Regulatory Know-How Transfer 4.6.2 Related Party Definition of “Net Sales” Required Post-Approval Development Activities 4.2.2 Reversion Products 12.6.2 Reversion Regulatory Materials 12.6.10 rimegepant Definition of “Licensed Compound” Royalty Term 6.5.1 Safety Data Exchange Agreement or SDEA 4.8 Senior Executives 3.8.1 [***] [***] Sublicensee 2.2 Subscription Agreement Recitals Supply Agreement 5.5.1(a) -14- Defined Term Section 4.4(aSupply Plan 5.5.2 Term 12.1 Termination Notice 12.3.2 Three-way Quality Agreement 5.5.3(b) Associate Section 8.11 Business Recitals CFC Section 4.17(fTitle 11 12.8 Trademark License Agreement 7.6.3 Triggering Event 5.7.1(b) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(fTwo-way Quality Agreement 5.5.3(a) Company Preamble Company Intellectual Property Section 4.8(a) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value VAT 6.15.2 zavegepant Definition of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)“Licensed Compound”
Appears in 1 contract
Samples: Collaboration and License Agreement (Biohaven Pharmaceutical Holding Co Ltd.)
Agreement Preamble. Ancillary Agreements Audited Financial Statements Section 4.4(a3.6(a) Associate Balance Sheet Section 8.11 Business Recitals CFC 3.6(a) Balance Sheet Date Section 4.17(f3.6(a) Basket Section 8.4(a) Benefit Plan Section 3.20(a) Cap Section 8.4(a) Certificate of Merger Section 2.4 Closing Section 3.1 2.2 Closing Date Section 3.1 Code 2.2 Closing Statement Section 4.17(f2.16(b) Company Preamble Company Intellectual Property Board Recitals Company Board Recommendation Section 4.8(a3.2(b) Company Owned Intellectual Property Charter Documents Section 4.8(b3.3 Consideration Spreadsheet Section 2.17(a) Consideration Conversion Agreement Section 2.3(a)(xvii) D&O Tail Policy Section 5.7(c) DGCL Recitals Direct Claim Section 8.5(c) Disputed Amounts Section 2.16(c)(iii) Dissenting Shares Section 2.2 Constitutional Documents 2.10 Drag-Along Notice Section 4.4(a5.4(b) Conversion Shares Drop Dead Date Section 2.5 Disclosure Schedule 9.1(d)(ii) Effective Time Section 4 Domestic Company Preamble Equity Value 2.4 Escrow Account Section 2.3(b)(iii) Escrow Agreement Section 2.3(a)(xiv) Estimated Cash Section 2.16(a) Estimated Closing Statement Section 2.16(a) Estimated Closing Working Capital Section 2.16(a) Estimated Indebtedness Section 2.16(a) Estimated Transaction Expenses Section 2.17(a)(i) FIRPTA Statement Section 2.3(a)(x) Fundamental Representations Section 8.4(c) Governmental Contracts Section 3.9(a)(viii) Indemnified Party Section 8.5 Indemnifying Party Section 8.5 Independent Accountant Section 2.16(c)(iii) Insurance Policies Section 3.16 Interim Balance Sheet Section 3.6 Interim Balance Sheet Date Section 3.6 Interim Financial Statements Section 3.6 Letter of the Company Transmittal Section 2.3(i2.11(c) FCPA Liabilities Section 4.19 HKIAC 3.7 Majority Holders Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii10.1(b) Material Adverse Effect Contracts Section 4.1 3.9(a) Material Contract Customers Section 4.9 OFAC 3.15(a) Material Suppliers Section 4.18(a3.15(b) OFAC Sanctions Merger Recitals Merger Sub Preamble Multiemployer Plan Section 4.18(a3.20(c) OFAC Sanctioned Person Option Termination Agreement Section 4.18(b2.3(a)(xvi) Ordinary Shares Outstanding Escrow Claims Section 2.5 Personal Information 8.6(b) Parent Preamble Parent Indemnitees Section 4.30 PFIC 8.2 Paying Agent Section 4.17(g2.11(b) Public Software Paying Agent Agreement Section 4.8(g2.3(a)(xiii) Purchased Shares Permitted Encumbrances Section 3.10(b) Post-Closing Adjustment Section 2.16(d)(i) Post-Closing Straddle Period Section 6.2 Pre-Closing Straddle Period Section 6.2 Qualified Benefit Plan Section 3.20(c) Representative Losses Section 10.1(c) Resolution Period Section 2.16(c)(ii) Restrictive Covenants Agreements Section 2.3(a)(ix) Review Period Section 2.16(c)(i) Section 280(G) Payments Section 5.11 Securityholder Indemnitees Section 8.3 Securityholder Releases Section 2.3(a)(xi) Securityholders’ Representative Preamble Statement of Objections Section 2.16(c)(ii) Stock Certificate Section 2.11(a) Stockholder Notice Section 5.4(b) Straddle Period Section 6.2 Support Agreements Section 2.3(a)(xi) Surviving Corporation Section 2.1 Restriction Period Third Party Claim Section 8.11 Restricted Share 8.5(a) Transfer Taxes Section 6.1(c) Undisputed Amounts Section 2.16(c)(iii) Union Section 3.21(b) Warrant Termination Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b2.3(a)(xv)
Appears in 1 contract
Samples: Agreement and Plan of Merger
Agreement Preamble. Ancillary Agreements Section 4.4(a) Associate Section 8.11 Business Recitals CFC Section 4.17(f) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(f) Company Preamble Company Intellectual Property Section 4.8(a) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Preamble
Appears in 1 contract
Samples: Series D Preferred Share Purchase Agreement (Itui International Inc.)
Agreement Preamble. Ancillary Agreements Adjusted Estimated Purchase Price Section 4.4(a2.1(a)(iv) Associate Adjustment Amount Section 8.11 Business Recitals CFC 2.2(c) Allocable Purchase Price Section 4.17(f2.5(b) Allocation Principles Section 2.5(b) Allocation Schedule Section 2.5(c) Available Insurance Policies Section 6.15 Balance Sheet Section 4.6(a) Balance Sheet Date Section 4.6(a) Bankruptcy and Equity Exception Section 3.1(a) Base Amount Section 2.1 Change In Control Customer Contracts Section 4.14(b) Closing Section 3.1 1.2 Closing Date Section 3.1 Code 1.2 COBRA Section 4.17(f4.12(a) Company Preamble Company Contracts Section 4.14(b) Company Disclosure Schedules Article IV Company Intellectual Property Section 4.8(a4.16(a)(i) Company Owned Organizational Documents Section 4.1(a) Company Plans Section 4.12(a) Company Technology Section 4.16(a)(ii) Computer Systems Section 4.16(b) Continuing Employees Section 6.11(a) Continuation Period Section 6.11(a) Contract Section 3.1(b) Copyrights Section 4.16(a)(iii) Customer Contract Section 4.14(a)(ix) D&O Indemnified Parties Section 6.12(a) Deal Communications Section 10.14(d) Deductible Section 9.3(a)(iii) Deficit Amount Section 2.2(e) De Minimis Threshold Section 9.3(a)(iv) Determination Date Section 2.2(b) Dispute Notice Section 2.2(b) Employees Section 4.12(a) Environmental Laws Section 4.13(b)(i) Environmental Liabilities Section 4.13(b)(ii) ERISA Section 4.12(a) ERISA Affiliate Section 4.12(a) Escrow Agent Section 2.3(a) Escrow Agreement Section 2.3(a) Estimated Purchase Price Section 2.1(a)(ii) Estimated Closing Date Net Working Capital Section 2.1(a)(i) Estimated Closing Statement Section 2.1(a)(i) Estimated Transaction Expenses Section 2.1(a)(i) Federal Health Care Program Section 4.19(c)(ii) Final Closing Statement Section 2.2(a) Financial Statements Section 4.6(a) Firm Section 10.14(a) Governmental Approval Section 3.2 Governmental Damages Section 7.2(d) Governmental Investigation Section 7.2(d) Granite Agreement Preamble Hazardous Materials Section 4.13(b) Hot Asset Section 2.5(c) Increase Amount Section 2.2(d) Indemnification Notice Section 9.5(a) Indemnifying Parties Section 9.2(a) Indemnitors Section 6.12(b) Independent Accounting Firm Section 2.2(b) Intellectual Property Rights Section 4.8(b4.16(a)(iii) Consideration Shares Interests Recitals Interim Period Section 2.2 Constitutional Documents 6.8(d) Manufacturer Contract Section 4.14(a)(x) Marks Section 4.16(a)(iii) Material Contract Section 4.14(a) Parent Preamble Parent Indemnified Parties Section 9.2(a) Parent’s Proposed Calculations Section 2.2(a) Patents Section 4.16(a)(iii) Permitted Lien Section 4.15 PHI Section 9.2(a)(iv) Pharmacy Section 4.6(a) Policies Section 4.17 Post-Signing Changes Section 10.13(b) Pre-Closing Insurance Policy Section 9.8 Privileged Deal Communications Section 10.14(d) Publicly Available Software Section 4.16(a)(iv) Purchase Price Section 2.1 Re-Calculated Closing Date Net Working Section 2.2(f) Capital Related Persons Section 4.21 Release Section 4.13(b)(iv) Release Date Section 9.3(a)(i) Remaining Disputed Items Section 2.2(b) Representatives Section 6.2(a) Requisite Approval Section 4.4(a) Conversion Shares Restraint(s) Section 2.5 7.1(b) Sale Recitals Securities Act Section 5.8 Seller Preamble Seller Parties Section 10.14(b) Short Period Section 6.8(d) Software Section 4.16(a)(v) Subsidiary Documents Section 4.2(b) Supplemental Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company 10.13(b) Takeover Proposal Section 2.3(i6.2(c) FCPA Tax Returns Section 4.19 HKIAC Section 9.17(b4.11(l) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Tax Sharing Agreement Section 6.1(f4.11(f) SDN List Taxes Section 4.18(b4.11(l) Secretary Technology Section 4.18(a4.16(a)(vi) Series D Investor(sThird Party Claim Section 9.5(b)(i) Recitals Series D Preferred Shares Recitals Series D Special Redemption Third Party Claim Notice Section 8.24 Series D Special Redemption Shareholder 9.5(b)(i) Trade Secrets Section 8.24 Special Redemption Consideration Shares 4.16(a)(iii) Walk-Away Date Section 8.24 Special Redemption Price 8.1(b)(i) WARN Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b4.12(a)
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Annual Financial Information Date Section 4.4(a3.15(a) Associate Assumed Contracts Section 8.11 Assumed Liabilities Section 2.03 Basket Section 7.02(e) Business Recitals CFC Employees Section 4.17(f3.14(c) Buyer Preamble Buyer Approvals Section 4.03 Buyer Disclosure Schedules Article IV Buyer Indemnitees Section 7.02(a) Buyer Preferred Stock Section 4.11(a) Buyer Sales Tax Section 5.09(f) Buyer SEC Documents Section 4.05(a) Bye-Laws Section 4.01 Claims Section 2.01(l) Closing Section 3.1 Closing 2.08 Confidentiality Agreement Section 5.01(a) Consideration Section 2.06(c) Copyrights Section 1.01 Covenant Contract Section 5.13(f) Customer Data Section 5.16 Equipment Section 2.01(b) Exchange Act Section 4.05(a) Excluded Assets Section 2.02 Excluded Claims Section 2.02(i) Excluded Liabilities Section 2.04 Excluded Seller Product Section 1.01 Financial Statements Section 3.15(a) Include Section 9.13 Including Section 9.13 Indemnification Cap Section 7.05 Indemnitee Section 7.02(c) Indemnitor Section 7.02(c) Investment Center Section 5.03 Israeli Tax Ruling Section 5.09(l) Leased Real Property Section 3.06 Losses Section 7.02(d) Material Contract Consents Section 3.09 Material Contracts Section 3.08 Notice of Claim Section 7.03(b) Parties Preamble Party Preamble Patents Section 1.01 Permits Section 2.01(i) Permitted Post-Signing Supplement Section 5.02(b) Possessing Party Section 5.01(c) Proceedings Section 3.07 Quarter Financial Information Date Section 3.1 Code 3.15(a) Receiving Party Section 4.17(f5.01(c) Company Retained Marks Section 5.04 Sale Section 5.20 Sales Tax Section 5.09(f) Xxxxxxxx-Xxxxx Act Section 4.05(d) SEC Section 4.05(a) Seller Preamble Company Seller Approvals Section 3.03 Seller Cash Consideration Section 2.06(b) Seller Disclosure Schedules Article III Seller Indemnitees Section 7.02(b) Seller Stock Consideration Section 2.06(b) Selling Parties Section 1.01 Share Encumbrances Section 3.23(a)(iii) Specially Designated Intellectual Property Section 4.8(a5.01(a) Company Owned Intellectual Property Subsidiary Sellers Recitals Subsidiary Sellers Cash Consideration Section 4.8(b2.06(a) Subsidiary Sellers Stock Consideration Shares Section 2.2 Constitutional Documents 2.06(a) Termination Date Section 4.4(a8.01(b)(i) Conversion Shares Trade Secrets Section 2.5 Disclosure Schedule 1.01 Trademarks Section 4 Domestic Company Preamble Equity Value of the Company 1.01 Transferred Assets Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred 2.01 Transferred Shares Recitals Series D Special Redemption Transferred Sub Recitals Transferred Sub Contracts Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)3.08
Appears in 1 contract
Samples: Asset Purchase Agreement (Marvell Technology Group LTD)
Agreement Preamble. Ancillary Agreements Alliance Manager Section 3.1 Assigning Party Section 8.9(b) Audited Party Section 11.4(d) Auditing Party Section 11.4(d) Commercialization Plan Section 7.3 Competing Product Section 2.7(a) Competing Product Exercise Period Section 2.8(b) Competing Product Expiry Date Section 2.8(b) Competing Product Negotiation Period Section 2.8(b) Competing Product ROFN Section 2.8(b) Competing Product Transaction Section 2.8(b) Development Plan Section 4.3 [ * ] [ * ] Effective Date Preamble Executive Officers Section 3.2 Expanded Indication Section 8.3(a) Field Expansion Exercise Period Section 2.8(a) Field Expansion Expiry Date Section 2.8(a) Field Expansion Negotiation Period Section 2.8(a) Field Expansion ROFN Section 2.8(a) Field Expansion Transaction Section 2.8(a) Force Majeure Event Section 15.1 ICC Section 14.3(a) Incremental Taxes Section 8.9(b) Indemnified Party Section 12.3 Indemnifying Party Section 12.3 Indirect Tax Section 8.9(a) JCC Section 3.4 JDC Section 3.3 Ji Xing Preamble Ji Xing Indemnitee(s) Section 12.2 Joint Commercialization Committee Section 3.4 Joint Development Committee Section 3.3 Joint Other Inventions Section 9.1(a)(ii) Joint Other Patents Section 9.2(a) Joint Steering Committee Section 3.2 JSC Section 3.2 License Section 2.1(b) Losses Section 12.1 [ * ] [ * ] OC-01 Compound Section 1.18 OC-01 Initial Technology Transfer Section 4.4(a) Associate [ * ] [ * ] OC-02 Compound Section 8.11 Business Recitals CFC 1.18 OC-02 Initial Technology Transfer Section 4.17(f4.4(b) Closing Oyster Point Preamble Oyster Point Indemnitee(s) Section 3.1 Closing Date 12.1 Oyster Point Trademarks Section 3.1 Code Section 4.17(f9.6(b) Company Parties Preamble Company Intellectual Property Section 4.8(a) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Party Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Pharmacovigilance Agreement Section 6.1(f5.6 Prior CDA Section 10.6 Product Infringement Section 9.3(b) SDN List Product Marks Section 4.18(b9.6(a) Secretary Region Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption 1.74 Remedial Action Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group 5.9 Royalty Term Section 8.5(b)) [ * ] [ * ] SEC Section 10.5(b) [ * ] [ * ] Sole Other Inventions Section 9.1(a)(ii) Subscription Agreement Section 8.2 Supply Agreement Section 6.3 Target Entity Section 1.3 Term Section 13.1(a) Third Party IP Section 2.10(a) Upstream Licensor Section 1.77
Appears in 1 contract
Samples: License and Collaboration Agreement (Oyster Point Pharma, Inc.)
Agreement Preamble. Ancillary Agreements Section 4.4(aBright House Partnership Agreement 6.06 Burdensome Condition 8.01(e) Associate Section 8.11 Business Recitals CFC Section 4.17(fCertificates 2.03(a)(ii) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(f2.01(b) Company Preamble Company Intellectual Property Section 4.8(aAdjusted Option 2.04(a) Company Owned Intellectual Property Section 4.8(bAdjusted RSU 2.04(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(aCompany Board Recommendation 4.02(b) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value Certificate of the Merger 2.01(c) Company Section 2.3(iCertificates 2.03(a)(ii) FCPA Section 4.19 HKIAC Section 9.17(bCompany International Plan 4.17(i) HK Subsidiary Preamble Indemnitee Section 9.1(aCompany Investment 4.06(c) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Company Material Contract 4.19(a)(ix) Company Merger Consideration 2.02(a)(i) Company Mergers 2.01(a)(iii) Company Option A Cash Consideration. 2.02(a)(i) Company Option A Merger Consideration 2.02(a)(i) Company Option A Stock Consideration 2.02(a)(i) Company Option B Cash Consideration 2.02(a)(i) Company Option B Merger Consideration 2.02(a)(i) Company Option B Stock Consideration 2.02(a)(i) Company Plans 4.17 Company Preferred Stock 4.05 Company Related Parties 10.02(h) Company RSU 2.04(b) Company SEC Documents 4.07 Company Securities 4.05(b) Company Stock Option 2.04(a) Company Stockholder Approval 4.02 Company Stockholder Meeting 6.02 Company Subsidiary Securities 4.06(b) Company Superior Proposal 6.03(e) Company Surviving Corporation 2.01(a)(ii) Term Section 4.9 OFAC Company Termination Fee 10.02(e) Company Transaction Litigation 8.10 Company Uncertificated Shares 2.03(a)(ii) Confidentiality Agreement. 6.03(b)(i) Consolidated Group Recitals Continuation Period 7.09 Continuing Employee 7.09 D&O Insurance 7.07(c) Debt Commitment Letter 5.21 Debt Financing 5.21 DGCL Recitals Director 2.04(c) Director RSU 2.04(c) Dissenting Shares 2.10(a) Effective Time 2.01(d) Election 2.02(a)(i) Election Deadline 2.03(a)(iv) Election Form. 2.03(a)(i) Election Form Record Date 2.03(a)(iii) Employee Communication Strategy 7.09(g) End Date. 10.01(b)(i) Exchange Agent 2.03(a)(ii) Exchange Fund. 2.03(a)(v) Financing Related Parties 10.02(h) First Company Merger 2.01(a)(ii) First Company Merger Effective Time 2.01(d) Former Employee 2.04(d) Former Employee Option 2.04(d) Former Employee RSU 2.04(d)(ii) Indemnified Person 7.07 Intended Tax Treatment Recitals Joint Proxy Statement/Prospectus 4.09 Lease 4.14(b) Liberty Broadband Recitals Mailing Date 2.03(a)(iii) Merger Communication 8.03(b) Merger Sub One Securities 5.05(b) Merger Sub Two and Three Securities 5.05(b) Merger Subsidiary One Preamble Merger Subsidiary Three Preamble Merger Subsidiary Two Preamble Merger Subsidiary Two Certificate of Merger 2.01(c) Merger Subsidiary Two Surviving Entity 2.01(a)(iii) Mergers 2.01(a)(iv) Multiemployer Plan 4.17(c) Term Section 4.18(aNew Charter Merger Consideration 2.02(b)(i) OFAC Sanctions New Charter Plans 7.09(d) New Charter Stock Issuance 7.03 Notional Adjusted Option 2.04(d) Notional Adjusted RSU 2.04(c) NYSE 4.03 Parent Preamble Parent Adjusted Option 2.05 Parent Adjusted RSU 2.05(c) Parent Adjusted Stock Award 2.05(b) Parent Board Recommendation 5.02(b) Parent Certificate of Merger 2.01(c) Parent Certificates 2.03(a)(ii) Parent Merger 2.01(a)(iv) Parent Merger Consideration 2.02(c)(i) Parent Merger Effective Time 2.01(d) Parent Plans 5.15(a) Parent Preferred Stock 5.05 Parent Regulatory Termination Fee 10.02(d) Parent RSU. 2.05(c) Parent SEC Documents 5.07 Parent Securities 5.05(b) Parent Stock Award 2.05(b) Parent Stock Option 2.05 Parent Stockholder Approval 5.02 Parent Stockholder Meeting 7.03 Parent Subsidiary Securities 5.06(b) Parent Superior Proposal. 7.04(e) Parent Surviving Entity 2.01(a)(iv) Parent Termination Fee 10.02(b) Parent Transaction Litigation 8.10 Parent Uncertificated Shares 2.03(a)(ii) Redemption Recitals Registration Statement 4.09 reportable transaction 5.14(e) Representatives 6.03(a) Represented Employee 7.09 Required Payment Amount 5.21 Second Company Merger 2.01(a)(iii) Second Company Merger Effective Time 2.01(d) Significant Subsidiary 4.06 Specified Company SEC Documents Article 4 Specified Parent SEC Documents Article 5 Title IV Plan 4.17(b) TWX 4.16(b) Term Section 4.18(aUncertificated Shares 2.03(a)(ii) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Voting Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Recitals
Appears in 1 contract
Samples: Agreement and Plan of Mergers
Agreement Preamble. Ancillary Agreements Assignment Agreement Section 4.4(a1.5(d) Associate Audited 2004 Financial Statements Section 8.11 Business Recitals CFC 3.3(a) Breach Notice Section 4.17(f7.1(d) Breakup Fee Section 7.2 [REDACTED] Claims Section 8.3(b) Claim Notice Section 8.3(b) Closing Section 3.1 1.4 Closing Date Section 3.1 Code Section 4.17(f) 1.4 Company Preamble Company Guaranty Section 5.17 Company Contracts Section 3.11(a) Company Membership Interests Preamble Company Permits Section 3.9(a) Company Required Consents Section 3.1(c) Company Required Statutory Approvals Section 3.1(d) Company Subsidiary Section 3.2(a) CTA Section 5.2(a) Damages Section 8.1 Deposit Section 1.6 Direct Claim Section 8.3(b) Easements Section 3.10(a) Escrow Agent Section 1.6 Escrow Agreement Section 1.6 Final Termination Date Section 7.1(c) Financing Arrangements Section 4.3 HQ Preamble [REDACTED] [REDACTED] HSR Act Section 5.2(a) Indemnified Party Section 8.3(a) Indemnified Person Section 5.7(a) Indemnifying Party Section 8.3(a) Independent Firm Section 5.11(g) Initial Termination Date Section 7.1(c) Defined Term Section Reference Insurance Policies Section 3.15 Intellectual Property Section 4.8(a3.13 Interim Financial Statements Section 3.3(b) Company Owned Intellectual Leased Real Property Section 4.8(b3.10(a) Consideration Shares Liability Threshold Section 2.2 Constitutional Documents 8.4(a) LIPA Guaranty Section 4.4(a) Conversion Shares 5.12 Loan Agreement Preamble Loan Repayment Amount Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share 1.3 O&M Agreement Section 6.1(f5.16 Operating Agreement Preamble Owned Real Property Section 3.10(a) SDN List Party Preamble Proceeding Section 4.18(b8.3(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Purchase Price Section 8.24 Subpart F Income 1.2 Purchaser Preamble Purchaser Demand Section 8.17(b9.3(b) Transaction Documents Purchaser Guaranteed Obligations Section 4.4(a9.3(a) UNCITRAL Rules Purchaser Guarantor Preamble Purchaser Guaranty Section 9.16(b9.3(a) United States Person Purchaser Required Consents Section 4.18(c4.2(b) WFOE Purchaser Required Statutory Approvals Section 4.2(c) [REDACTED] Securities Act Section 4.5 Seller Preamble Xunlei Group Seller Required Consents Section 8.5(b)2.1(c) Seller Required Statutory Approvals Section 2.1(d) Sellers Preamble Services Agreement Section 5.16 Shellfish Guaranty Section 5.12
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Alliance Manager Section 4.4(a3.3(a) Associate Arbitral Decision Section 8.11 Business Recitals CFC 14.2(b) Claims Section 4.17(f) Closing 12.1 Clinical Agreement Section 3.1 Closing Date 5.4 Commercialization Plan Section 3.1 Code 6.2 Common Stock Section 4.17(f) 8.3 Company Preamble Company Intellectual Property Board Section 4.8(a11.6(c) Company Owned Intellectual Property Development Activities Section 4.8(b5.4 Company Development Expenses Section 5.7(a) Consideration Company Indemnitees Section 12.1 Confidential Information Section 11.1 Co-Promotion Agreement Section 6.6 Co-Promotion Right Section 6.6 DoJ Section 16.19(a) Effective Date Section 14.1 Exchange Act Section 11.4(c) Execution Date Preamble Existing Inventory Section 7.3(a) Existing Regulatory Documentation Section 13.2(k) Existing Study Section 5.3(a) Facility Section 7.1(b) [*] Section 5.3(a) FTC Section 16.19(a) Generic Market Data Section 8.7(c)(i(3) HSR Conditions Section 16.19(b) IMMU-132 Information Section 11.1 Indemnitee Section 12.3 Indemnitor Section 12.3 JCC Section 3.2 JDC Section 3.2 Joint Inventions Section 10.1 Joint Patents Section 10.3(c) JPC Section 3.2 JSC Section 3.1(a) Legal Proceeding Section 16.20 Letter Agreement Section 16.6 Licensee Preamble Licensee Indemnitees Section 12.2 Licensee Xxxx(s) Section 14.5(d) Losses Section 12.1 CONFIDENTIAL TREATMENT [*] Indicates that text has been omitted which is the subject of a confidential treatment request. This text has been separately filed with the SEC. Definition Reference Manufacturing Agreements Section 7.3(d) Marks Section 10.8(a) Match Period Section 11.6(b) Milestone Event Section 8.4 New Affiliate Date Section 2.11 No-Shop Start Date Section 11.6(a) NSCLC Section 5.3(a) Other Licensed Molecule Section 2.10 Other Royalty Term Section 8.7(b)(ii) Parties Preamble Party Preamble Product Infringement Section 10.4(a) Publication Section 11.5 Purchased Shares Section 2.2 Constitutional Documents 8.3 Qualifying Sublicensee Section 4.4(a8.2(a) Conversion Shares [*] [*] ROFN Election Notice Section 2.5 Disclosure Schedule 2.9 ROFN Notice Section 4 Domestic Company Preamble Equity Value 2.9 ROFN Product Section 2.9 Sale of the Company Proposal Section 2.3(i11.6(c) FCPA SCLC Section 4.19 HKIAC 5.3(a) Sole Inventions Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)10.1
Appears in 1 contract
Samples: Development and License Agreement (Seattle Genetics Inc /Wa)
Agreement Preamble. Ancillary Agreements Section 1.7(b)(iv) Assignment of Intellectual Property 1.7(b)(iii) Assumed Liabilities 1.3 Assumption Agreement 1.7(b)(ii) Bill of Sale 1.7(b)(i) Business Recitals Buyer Preamble Buyer Indemnified Parties 6.2 Buyer Parent Preamble Buyer Parent Common Stock 4.4(a) Associate Section 8.11 Business Recitals CFC Section 4.17(f) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(f) Company Preamble Company Intellectual Property Section 4.8(a) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section Buyer Parent Disclosure Schedule Article IV Buyer Parent Equity Awards 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(iBuyer Parent Financial Statements 4.5(a) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Buyer Parent Material Adverse Effect Section 4.1 4.8 Buyer Parent Stock Options 4.4(a) Buyer Parent Stock Plans 4.4(a) Buyer Parent Warrants 4.4(a) Cash Consideration 1.6 Circular 5.4(c) Closing 1.7(a)(i) Closing Date 1.7(a)(i) control 2.14 Demand Request 5.11(a) Direct Claim 7.4(c) Encumbrances 2.4 Exchange Act 4.9 Excluded Assets 1.2 Excluded Liabilities 1.4 Financial Data 2.5 Form S-1 4.9 Fundamental Representations 6.1(a)(i) Governmental Authority 2.3 Hazardous Materials 2.12 Indemnified Party 6.4(a) Indemnifying Party 6.4(a) Law 2.3 Loan Amount 5.1 Lock-Up 1.7(b)(iv) Losses 6.2 Material Adverse Effect 2.1 Material Contract Section 4.9 OFAC Section 4.18(a2.13 Parent Shares 1.6 Patent Rights 2.10(b) OFAC Sanctions Section 4.18(aPermits 2.8 Person 2.10(b) OFAC Sanctioned Person Section 4.18(bProposal 5.8(a)(i) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(gProposed Registration 5.10(a) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(fAssets 1.1 Purchased Patent Rights 2.10(d) SDN List Section 4.18(bReal Property 2.12 Related Party 2.14 Representatives 5.3 Rule 144 5.11(a) Secretary Section 4.18(aSEC 4.9 SEC Reports 4.9 Securities Act 4.9 Seller Preamble Seller Indemnified Parties 6.2 Seller Intellectual Property 2.10(b) Series D Investor(sSubsidiary 4.4(b) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(bSuperior Proposal 5.8(e) Third Party Claim 6.4(b) Transaction Documents Section 4.4(aConsideration 1.6 Wesana Board 5.8(c) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Wesana Parent Preamble Xunlei Group Section 8.5(bWesana Parent Shareholder Meeting 5.4(a)
Appears in 1 contract
Samples: Asset Purchase Agreement (Lucy Scientific Discovery, Inc.)
Agreement Preamble. Ancillary Agreements Alliance Manager Section 4.4(a3.3(a) Associate Arbitral Decision Section 8.11 Business Recitals CFC 14.2(b) Claims Section 4.17(f) Closing 12.1 Clinical Agreement Section 3.1 Closing Date 5.4 Commercialization Plan Section 3.1 Code 6.2 Common Stock Section 4.17(f) 8.3 Company Preamble Company Intellectual Property Board Section 4.8(a11.6(c) Company Owned Intellectual Property Development Activities Section 4.8(b5.4 Company Development Expenses Section 5.7(a) Consideration Company Indemnitees Section 12.1 Confidential Information Section 11.1 Co-Promotion Agreement Section 6.6 Co-Promotion Right Section 6.6 DoJ Section 16.19(a) Effective Date Section 14.1 Exchange Act Section 11.4(c) Execution Date Preamble Existing Inventory Section 7.3(a) Existing Regulatory Documentation Section 13.2(k) Existing Study Section 5.3(a) Facility Section 7.1(b) First Indications Section 5.3(a) FTC Section 16.19(a) Generic Market Data Section 8.7(c)(i(3) HSR Conditions Section 16.19(b) IMMU-132 Information Section 11.1 Indemnitee Section 12.3 Indemnitor Section 12.3 JCC Section 3.2 JDC Section 3.2 Joint Inventions Section 10.1 CONFIDENTIAL TREATMENT [*] Indicates that text has been omitted which is the subject of a confidential treatment request. This text has been separately filed with the SEC. Definition Reference Joint Patents Section 10.3(c) JPC Section 3.2 JSC Section 3.1(a) Legal Proceeding Section 16.20 Letter Agreement Section 16.6 Licensee Preamble Licensee Indemnitees Section 12.2 Licensee Xxxx(s) Section 14.5(d) Losses Section 12.1 Manufacturing Agreements Section 7.3(d) Marks Section 10.8(a) Match Period Section 11.6(b) Milestone Event Section 8.4 New Affiliate Date Section 2.11 No-Shop Start Date Section 11.6(a) NSCLC Section 5.3(a) Other Licensed Molecule Section 2.10 Other Royalty Term Section 8.7(b)(ii) Parties Preamble Party Preamble Product Infringement Section 10.4(a) Publication Section 11.5 Purchased Shares Section 2.2 Constitutional Documents 8.3 Qualifying Sublicensee Section 4.4(a8.2(a) Conversion Shares Reimbursable Costs Section 2.5 Disclosure Schedule 16.20 ROFN Election Notice Section 4 Domestic Company Preamble Equity Value 2.9 ROFN Notice Section 2.9 ROFN Product Section 2.9 Sale of the Company Proposal Section 2.3(i11.6(c) FCPA SCLC Section 4.19 HKIAC 5.3(a) Sole Inventions Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)10.1
Appears in 1 contract
Samples: Development and License Agreement (Seattle Genetics Inc /Wa)
Agreement Preamble. Ancillary Agreements Section 4.4(aAssumed Contracts 2.1 Assumed Liabilities 3.1 Assignment and Assumption Agreement 5.2(a)(iii) Associate Section 8.11 Audited Financial Statements 7.6 Azaribine 2.2 Balance Sheet 2.1(a) Bxxx of Sale 5.2(a)(ii) Bulk Sales Laws 8.9 Business Recitals CFC Section 4.17(fBusiness Patents 6.20(a) Chicago License Assignment Agreement 5.2(a)(iv) Closing Section 3.1 5.1 Closing Date Section 3.1 Code Section 4.17(f5.1 Closing Date Shares 4.1(b)(i) Company Preamble Company Intellectual Property Section 4.8(aCommon Stock 4.1(b) Company Owned Intellectual Property Section 4.8(bContract(s) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(aRequiring Consent 6.11(b) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(iArticle VI Escrow Agreement 4.2 Escrow Agent 4.1(b)(ii) FCPA Section 4.19 HKIAC Section 9.17(bEscrow Shares 4.1(b)(ii) HK Subsidiary Excluded Assets 2.2 Financial Statements 6.8(a) GAAP 7.6 Gxxxxxxx Consent and Assignment Agreement 5.2(a)(v) Income Statement 2.1(a) Indemnifying Parties 9.3(a) Interim Financial Statements 6.8(a) Losses 9.2 Parent Preamble Indemnitee Section 9.1(aParent Financial Statements 7.6 Parent SEC Documents 7.5 Proceedings 6.6 Purchase Price 4.1(b) Indemnifiable Loss Section 9.1(aPurchaser Preamble Purchaser Indemnified Parties 9.2 Retained Liabilities 3.2 Seller Preamble Shareholder(s) Investor Preamble Investor’s Partners Section 8.17(bShares 4.1(b)(ii) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(bURL Consent and Assignment Agreement 5.2(a)(v) Licenses Section 4.8(eTax(es) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii6.19(i)(i) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(aTax Return 6.19(i)(ii) OFAC Sanctions Section 4.18(aTransferred Assets 2.1 Univertical Assignment 6.28(a) OFAC Sanctioned Person Section 4.18(bUnivertical 6.28(a) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section A5 EXHIBIT B PATENTS AND PATENT APPLICATIONS EXHIBIT C ESCROW AGREEMENT EXHIBIT D FORM OF BXXX OF SALE EXHIBIT E FORM OF ASSIGNMENT AND ASSUMPTION AGREEMENT EXHIBIT F CHICAGO LICENSE ASSIGNMENT AGREEMENT EXHIBIT G URL-GXXXXXXX CONSENT AND ASSIGNMENT AGREEMENT EXHIBIT H PGNX-URL CONSENT AND ASSIGNMENT AGREEMENT EXHIBIT I PATENT ASSIGNMENT EXHIBIT J REGISTRATION RIGHTS AGREEMENT EXHIBIT K CROSS RELEASE ANNEX 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)BALANCE SHEETS, STATEMENTS OF UNAPPROPRIATED RETAINED EARNINGS AND SUMMARY OF OPERATIONS
Appears in 1 contract
Samples: Agreement and Plan of Reorganization (Progenics Pharmaceuticals Inc)
Agreement Preamble. Ancillary Agreements Assets Section 4.4(a1.01 Assigned Contracts Section 1.01(b) Associate Assignment and Assumption Agreement Section 8.11 2.02(b) Assumed Liabilities Section 1.03(a) Xxxx of Sale Section 2.02(a) Breaching Party Section 9.05 Business Recitals CFC Business Intellectual Property Section 4.17(f) 4.12 Claimant Section 7.03 Closing Section 3.1 2.01 Closing Date Section 3.1 Code 2.01 Confidential Information Section 4.17(f9.01(b) Company Disagreement Notice Section 7.05 Disclosure Schedules Article IV Election Notice Section 7.04 Excluded Assets Section 1.02 Excluded Liabilities Section 1.03(b) Financial Statements Section 4.06(a) Fundamental Representations Section 7.07 Holdings Preamble Company Intellectual Property Indemnification Basket Section 4.8(a) Company Owned Intellectual Property 7.08 Indemnification Cap Section 4.8(b) Consideration Shares 7.08 Indemnification Notice Section 2.2 Constitutional Documents 7.03 Indemnifying Party Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable 7.03 Indemnity Loss Section 9.1(a7.01 Injured Party Section 9.05 Litigation Notice Section 7.03 Preliminary Allocation Section 1.05 Purchaser Preamble Purchaser Indemnified Parties Section 7.01 Purchase Price Section 1.04 Real Property Leases Section 4.10 Reduct License Agreement Section 4.12 Restricted Area Section 9.02(a) Investor Restricted Period Section 9.02(a) Seller Preamble Investor’s Partners Seller Indemnified Parties Section 8.17(b) Key 7.02 Transferred Employee Section 4.22 Key Holders Preamble 10.02 Assigned Contracts Schedule Standard Industrial Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization – Gross, dated October 13, 2009, by and between Seller and PAJAP, Ltd. Co., for the office building located at 0000 Xxxxx Xxxxxxx XX - Xxxxx X, Xxxxxxxxxxx, XX 00000. Deposits Schedule Deposit in the amount of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)$2,000 under that certain Standard Industrial Lease – Gross, dated October 13, 2009, by and between Seller and PAJAP, Ltd. Co., for the office building located at 0000 Xxxxx Xxxxxxx XX - Xxxxx X, Xxxxxxxxxxx, XX 00000. Assets Schedule Vehicles: - 42 - Locating Equipment: Computers: Other Assets: 4 Samsung Cameras 31 Kodak Cameras 38 Verizon Air Cards 35 Samsung Storm Mobile Phones
Appears in 1 contract
Samples: Asset Purchase Agreement (Geospatial Holdings, Inc.)
Agreement Preamble. Ancillary Agreements Borrowed Money Indebtedness Section 4.4(a1.04(b)(i)(A) Associate Business Entity Section 8.11 Business Recitals CFC 5.07(a) Canadian NewCo Section 4.17(f) 5.19 Closing Section 3.1 1.04(a) Closing Date Section 3.1 Code 1.04(a) Collar Amount Section 4.17(f1.05(d) Company Preamble Company Intellectual Property Policies Section 4.8(a3.18 Company Savings Plan Section 7.02(c) Company Owned Intellectual Property -75- NAI-1502820106v1 Term Section 4.8(bConfidentiality Agreement Section 5.02(a) Consideration Shares Continuing Employees Section 2.2 Constitutional Documents 7.01(b) CSP Transfer Date Section 4.4(a7.02(c) Conversion Shares CTDEEP Section 2.5 Disclosure Schedule 1.04(d)(xiii) D&O Costs Section 4 Domestic Company 5.13(b) D&O Expenses Section 5.13(b) D&O Indemnifiable Claim Section 5.13(b) D&O Indemnified Person Section 5.13(a) D&O Indemnifying Party Section 5.13(b) Debt Payoff Recipients Section 1.04(b)(i)(A) DSS Companies Preamble Equity Value of the Company ECAF Section 2.3(i1.04(d)(xiii) FCPA Effective Date Preamble Employee List Section 4.19 HKIAC 7.01(b) Employee Plans Section 9.17(b3.10(a) HK Subsidiary Preamble Indemnitee Employee Transfer Date Section 9.1(a7.01(b) Indemnifiable Loss Estimated Final Working Capital Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key 1.03 Excluded Employee Section 4.22 Key Holders Preamble Lease 7.01(b) Financial Statements Section 4.7(b3.05(a) Licenses Final Closing Statement Section 4.8(e1.05 Foreign Plan Section 3.10(i) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Form III Section 2.3(ii1.04(d)(xiii) General Enforceability Exceptions Section 2.02 HSR Clearance Section 5.06(a) Insurance Policies Section 3.18 Interim Balance Sheet Section 3.05(a) In-scope Employee Section 7.01(b) Joint Contract Section 3.19(d) Material Adverse Effect Contracts Section 4.1 Material Contract 3.14(a)(xii) Parent Policies Section 4.9 OFAC 3.18 Permits Section 4.18(a3.09(b) OFAC Sanctions PolyOne Savings Plan Section 4.18(a7.02(b) OFAC Sanctioned Person Purchase and Sale Section 4.18(b1.04(a) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Purchase Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)1.02
Appears in 1 contract
Samples: Equity Purchase Agreement
Agreement Preamble. Alberta Order Section 3.03(b) Allocations Section 9.01(a) Ancillary Agreements Section 4.4(a11.03 Annualized Business Three Month Net Sales Amount Section 11.03 Appraisal Firm Section 9.01(a) Associate Asset Allocation Section 8.11 9.01(a) Asset Conveyance Documents Section 2.02(a) Assumed Benefit Agreement Section 11.03 Assumed Benefit Plan Section 11.03 Assumed Benefit Plan Assets Section 1.02(a)(xiii) Assumed Canadian Liabilities Section 11.03 Assumed Credit Support Obligations Section 6.19(a) Assumed Liabilities Section 1.04(a) Balance Sheet Section 4.04(b) Business Recitals CFC Section 4.17(f11.03 Business 401(k) Plan Section 1.01(h)(i) Business Benefit Agreement Section 11.03 Business Benefit Plan Section 11.03 Business Continuing Credit Support Obligation Section 6.19(b) Business Day Section 11.03 Business Employee Section 11.03 Business Financial Statements Section 4.04(b) Business Insurance Policies Section 1.02(a)(xv) Business Material Adverse Effect Section 11.03 Business Material Agreements Section 4.14(a) Business NDA Section 11.03 Canada Business Employees Section 11.03 Canadian Allocation Section 9.01(a) Canadian Seller Section 11.03 Canadian Transferred Assets Section 11.03 CBA Section 4.08(a) Closing Section 3.1 2.01 Closing Date Section 3.1 2.01 Closing Date Payment Section 2.02(b) Closing Eligible Capital Expenditures Section 2.03(a) Closing Working Capital Section 2.03(a) Code Section 4.17(f11.03 Columbus Industrial Revenue Bonds Section 11.03 Commercial Operation Section 11.03 Confidentiality Agreement Section 11.03 Continuation Period Section 11.03 Contracts Section 1.02(a)(vii) Company Preamble Company Intellectual Property control Section 4.8(a11.03 Controlled Group Liability Section 4.07(b) Company Owned Intellectual Property Controlling Party Section 4.8(b10.08(b) Consideration Shares Credit Support Obligations Section 2.2 Constitutional Documents 11.03 Current Assets Section 4.4(a2.03(d) Conversion Shares Current Liabilities Section 2.5 Disclosure Schedule 2.03(d) Data Processing Agreement Section 4 Domestic Company Preamble 11.03 Debt Amount Section 11.03 DOJ Section 6.04(a) Effect Section 11.03 Eligible Capital Expenditures Section 11.03 Employee List Section 6.07(a) Environmental Indemnity Claims Section 10.08 Environmental Laws Section 11.03 Environmental Liabilities Section 11.03 Environmental Permits Section 4.11(a)(iii) Environmental Proceedings Section 4.11(a)(iv) Equity Value of the Company Allocation, Section 2.3(i9.01(a) ERISA Section 11.03 Exchange Act Section 3.03(b) Excluded Assets Section 1.02(b) Extraordinary Maintenance and Repair Expenditures Section 11.03 FCPA Section 4.19 HKIAC FERC Section 9.17(b6.04(a) HK Subsidiary Preamble Indemnitee FERC Approval Section 9.1(a3.03(b) Indemnifiable Loss Final Order Section 9.1(a11.03 FOLA Section 11.03 FOLR Section 11.03 FTC Section 6.04(a) Investor Preamble Investor’s Partners GAAP Section 8.17(b11.03 Geneva Pension Plan Section 11.03 Georgia Power Contract Section 11.03 Governmental Approval Section 3.03(b) Key Employee Governmental Entity Section 4.22 Key Holders Preamble 3.03(b) GST Section 11.03 Hazardous Materials Section 11.03 Historic Remains Section 11.03 Hong Kong Business Employees Section 11.03 HSR Act Section 3.03(b) Income Tax Section 11.03 Income Tax Claim Section 10.04(b) Indebtedness Section 11.03 Indemnified Party Section 10.04(a) Indemnifying Party Section 10.04(a) Intellectual Property Allocation Section 9.01(a) Intellectual Property License Agreement Section 11.03 Intellectual Property Rights Section 11.03 Intermediary Section 9.12 Inventory Section 1.02(a)(ii) IRS Section 11.03 Japan Business Employees Section 11.03 JDA Section 6.02(h) Judgment Section 3.03(a) knowledge of Seller Section 11.03 Law Section 3.03(a) Lease Buyout Amount Section 4.7(b6.13 Leased Real Property Section 4.12(b) Licenses Liabilities Section 4.8(e11.03 Liabilities Assumption Documents Section 2.02(b) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Lien Date Section 2.3(ii9.03 Liens Section 11.03 Losses Section 10.01(a) Material Adverse Effect Section 4.1 11.03 Material Contract Lease Section 4.9 OFAC 11.03 Material Third Party Lease Section 4.18(a4.14(a)(ix) OFAC Sanctions Monthly Financial Reports Section 4.18(a6.14(c) OFAC Sanctioned Non-Controlling Party Section 10.08(b) Non-U.S. Assumed Benefit Plan Section 4.07(d) Non-U.S. Business Employees Section 11.03 Notice of Disagreement Section 2.03(b) NYSE Section 11.03 Outside Date Section 8.01(b)(i) Owned Real Property Section 4.12(a) Permits Section 1.02(a)(vi) Permitted Liens Section 4.12(d) Person Section 4.18(b11.03 Port Wentworth Budget Section 4.20(a) Ordinary Shares Port Wentworth Project Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction 11.03 Post-Closing Tax Period Section 8.11 Restricted Share Agreement 11.03 Power Act Section 6.1(f3.03(b) SDN List Pre-Closing Environmental Liabilities Section 4.18(b11.03 Pre-Closing Maintenance CapEx Budget Section 4.20(b) Secretary Pre-Closing Tax Period Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption 11.03 Project Completion Deadline Section 8.24 Series D Special Redemption Shareholder 11.03 Property Tax Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption 9.03 Purchase Price Section 8.24 Subpart F Income 1.01 Purchaser Preamble Purchaser 401(k) Plan Section 8.17(b6.07(h)(i) Transaction Documents Purchaser Disclosure Letter Article III Purchaser Fundamental Representations Section 4.4(a11.03 Purchaser Indemnitees Section 10.01(a) UNCITRAL Rules Purchaser Material Adverse Effect Section 9.16(b11.03 Purchaser Portion Section 1.05(a) United States Person Purchaser Sub Recitals Purchaser Welfare Plans Section 4.18(c6.07(g)(i) WFOE Real Property Allocation Section 9.01(a) Records Section 1.02(a)(xi) Regulatory Legal Proceeding Section 11.03 Release Section 11.03 Representatives Section 11.03 Responsive Action Section 10.08(a) Retained Credit Support Obligations Section 6.19(b) Retained Environmental Liabilities Section 11.03 Retained Liabilities Section 1.04(b) Retained Names Section 1.02(b)(x) Retained Tax Liabilities Section 1.04(b)(iv) Return Date Section 9.01(a) Review Law Section 11.03 RPR Section 6.17(a)(i) Scheduled Intellectual Property Section 1.02(a)(v) SEC Section 11.03 Section 1031 Section 9.12 Securities Act Section 11.03 Seller Preamble Xunlei Group Seller Business Section 8.5(b)11.03 Seller Continuing Credit Support Obligation Section 6.19(a) Seller Disclosure Letter Article IV
Appears in 1 contract
Samples: Purchase Agreement (Weyerhaeuser Co)
Agreement Preamble. Ancillary Agreements Antitrust Law Master Agreement Audit Team Section 4.4(a9.6(a) Associate Section 8.11 Business Recitals CFC Section 4.17(f) Closing Section 3.1 Closing Date Section 3.1 Bankruptcy Code Section 4.17(f8.8 Business Day Master Agreement Celgene Preamble Celgene Corp. Preamble Celgene RIVOT Preamble Celgene Indemnified Parties Section 13.2(a) Company Preamble Company Intellectual Property DEFINITION SECTION Celgene Manufacturing Responsibilities Section 4.8(a4.1(a) Company Owned Intellectual Property Challenge Section 4.8(b14.3)(d) Consideration Shares Challenging Party Section 2.2 Constitutional Documents 14.3(d) Combination Product Section 4.4(a1.37 Commercialization/Commercialize Master Agreement Commercialization Report Section 2.1(c) Conversion Shares Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 2.5 Disclosure Schedule 10.3(b) Competitive Program Section 4 Domestic Company Preamble Equity Value of the Company 8.6(b)(iv) Competitive Program Party Section 2.3(i8.6(b)(iv) FCPA Control/Controlled Master Agreement Cooperating Party Section 4.19 HKIAC Section 9.17(b11.3(b)(iii) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Cover/Covering/Covered Master Agreement Cure Period Section 8.11 Restricted Share 14.3(b)(i) Develop/Development Master Agreement Development Costs Master Agreement Disclosing Party Section 6.1(f11.1 Dispute Section 15.1 Earlier Patent Section 10.8 Electronic Delivery Section 15.14 Execution Date Preamble FDA Master Agreement FDA Master Agreement force majeure event Section 15.5 IND Master Agreement Indication Master Agreement [**] Section 9.7(a) SDN List Invalidity Claim Section 4.18(b10.4(b) Secretary Joint Inventions Section 4.18(a10.1(c) Series D Investor(sJoint Patents Section 10.1(c) Recitals Series D Preferred Shares Recitals Series D Special Redemption Know-How Master Agreement Law Master Agreement Licensed Branding Section 8.24 Series D Special Redemption Shareholder 6.2(c) Licensed Product Data Section 8.24 Special Redemption Consideration Shares 14.4(c) Manufacturing Costs Master Agreement Master Agreement Introduction Material Breach Section 8.24 Special Redemption Price 14.3(b)(i) Metabolic Target Master Agreement Ongoing Clinical Trial Section 8.24 Subpart F Income 3.1(a) Party/Parties Preamble Patents Master Agreement Payee Party Section 8.17(b9.7(a) Transaction Documents Paying Party Section 4.4(a9.7(a) UNCITRAL Rules Person Master Agreement Phase I Study Master Agreement DEFINITION SECTION Phase II Study Master Agreement Phase III Study Master Agreement Product Trademarks Section 9.16(b6.2(a) United States Person Prosecuting Party Section 4.18(c10.2(d)(i) WFOE Preamble Xunlei Group Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 8.5(b)14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.1 Requesting Party Section 11.3(b)(iii) Royalty Term Section 9.3(b) SEC Section 11.3(b)(i) Selling Party Section 1.37 Term Section 14.1 Therapeutic Modality Section 8.6(a) Third Party Master Agreement Third Party Contractors Section 8.2(a)(ii) Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4(a) Article II.
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Amended and Restated Indenture Section 4.4(a1.1(c) Associate Articles Section 8.11 Business 2.2 business day Section 8.3(a) Cash-Paid Notes Tender Offer Recitals CFC Cash-Paid Notes Tender Offer Conditions Section 4.17(f1.2(a) Cash-Paid Notes Tender Offer Documents Section 1.2(b) Closing Section 3.1 1.6 Closing Date Section 3.1 1.6 Code Section 4.17(f2.10(a)(iii) collective bargaining agreement Section 8.3(a) Company Preamble Company Intellectual Property Disclosure Schedule ARTICLE II Company Employees Section 4.8(a2.10(c)(i) Company Owned Intellectual Property Plan Section 4.8(b2.10(c)(i) Consideration Shares Company Shareholder Approval Section 6.1(c) Company Shareholder Meeting Section 5.1(a) Company Warrants Section 2.3(a) Confidentiality Agreement Section 5.2(b) Consent Solicitation Recitals Contract Section 2.5(a) control Section 8.3(a) controlled Section 8.3(a) Term Section controlled by Section 8.3(a) Dataroom Section 2.2 Constitutional Documents Debt Purchaser Preamble Deutsche Bank Section 4.4(a5.1(a) Conversion Shares Equity Financing Section 2.5 Disclosure Schedule 3.7(a) Equity Financing Commitment Section 4 Domestic Company 3.7(a) Equity Purchaser Recitals ERISA Section 2.10(c)(i) ERISA Affiliate Section 2.10(c)(ii) Exchange Act Section 2.5(b) executive officer Section 8.3(a) Financing Section 3.7(a) Financing Commitments Section 3.7(a) Foreign Antitrust Laws Section 2.5(b) Fund Section 3.7(a) generally accepted accounting principles Section 8.3(a) Governmental Entity Section 2.5(b) HTCC Preamble Equity Value of the Company HTCC Sub Recitals Hungarian Telecom Section 2.3(i3.7(a) FCPA IRS Section 4.19 HKIAC 2.10(a)(iii) knowledge Section 9.17(b8.3(a) HK Subsidiary Preamble Indemnitee Law Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b2.5(a) Licenses Section 4.8(e2.6(b) Management Founder Lien Section 2.3(a) Magyar Telecom Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 2.1 Material Contract Section 4.9 OFAC 2.12(a) Memorandum of Incorporation Section 4.18(a2.2 MEP Section 3.1 New Shareholder Loan Section 1.4(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share New Shareholder Loan Agreement Section 6.1(f1.4(a) SDN List Notice Section 4.18(b5.1(b) Secretary Term Section 4.18(aOrder Section 2.5(a) Series D Investor(sperson Section 8.3(a) PIK Notes Tender Offer Recitals Series D Preferred PIK Notes Tender Offer Conditions Section 1.1(a) PIK Notes Tender Offer Documents Section 1.1(d) Proposed Amendments Section 1.1(c) Purchaser Directors Section 5.1(a) Purchasers Recitals Regulations S Section 8.3(a) Regulatory Requirements Section 2.5(b) Requisite Noteholder Consents Section 1.1(c) Roll-Over Section 3.7(a) Roll-Over Commitments Section 3.7(a) Xxxxxxxx-Xxxxx Act Section 2.7(c) SEC Section 2.7(a) SEC Reports Section 2.7(a) Securities Act Section 2.7(a) Senior Facilities Agreement Annex 1.5 Seller Loan Agreement Recitals Shares Recitals Series D Special Redemption Subordinated Loan Agreement Annex 1.5 Subordinated Term Loan Recitals subsidiaries Section 8.24 Series D Special Redemption Shareholder 8.3(a) subsidiary Section 8.24 Special Redemption Consideration Shares 8.3(a) Tag Along Agreement Section 8.24 Special Redemption Price 2.20 Tax Return Section 8.24 Subpart F Income 2.14(b) Taxes Section 8.17(b2.14(b) Transaction TDC Recitals TDC Agreement Recitals TDC Documents Section 4.4(a5.9 Termination Date Section 7.1(c) UNCITRAL Rules Trustee Section 9.16(b1.1(c) United States Person under common control with Section 4.18(c8.3(a) WFOE Preamble Xunlei Group U.S. Section 8.5(b)2.5(b) Term Section Voting Agreement Section 3.7(b) 2004 Notes Recitals 2006 PIK Notes Recitals 2006 PIK Notes Indenture Recitals 2007 Notes Recitals
Appears in 1 contract
Samples: Debt Restructuring Agreement (Invitel Holdings a/S)
Agreement Preamble. Ancillary Agreements Audited Financial Information Section 4.4(a) Associate Balance Sheet Dispute Notice Section 8.11 2.5(b) Broker Section 4.19 Business Recitals CFC Buyer Preamble Buyer Disclosure Letter Article V Buyer Indemnified Parties Section 4.17(f9.2(a) Buyer Permits Section 5.4(a) Buyer Plans Section 6.3(b) Cap Section 9.7(a) Closing Section 3.1 Closing Balance Sheet Section 2.5(a) Closing Date Section 3.1 Code Closing Date Working Capital Section 4.17(f2.5(a) Closing Payment Section 2.1 Closing Statement Section 2.5(a) Company Preamble Recitals Company Intellectual Property Benefit Plans Section 4.8(a4.15(a) Company Owned Intellectual Property Business Personnel Section 4.8(b4.14(a) Consideration Shares Company Indemnified Parties Section 2.2 Constitutional Documents 6.13(a) Company IT Systems Section 4.9(g) Company Permits Section 4.13(a) Confidentiality Agreement Section 6.4(a) Confirmation Certificate Section 2.5(b) Damages Section 9.2(a) Terms Cross Reference in Agreement Deductible Section 9.7(a) Designated Representative Section 6.19 Determination Date Section 2.5(b) Disclosure Letters Article V Employees Section 4.15(a) ERISA Section 4.15(a) Escrow Termination Date Section 9.9 Estimated Working Capital Deficiency Section 2.4 Estimated Working Capital Excess Section 2.4 Existing Territory Section 6.17(a)(ii) Fee Liens Section 4.17(d)(i) Final Working Capital Adjustment Section 2.5(c) Financial Information Section 4.4(a) Conversion Shares Future Territory Section 2.5 Disclosure Schedule 6.17(a)(ii) GAAP Section 4 Domestic Company Preamble Equity Value of the Company 4.4(a) Governmental Approvals Section 2.3(i6.5(a) FCPA Governmental Entity Section 4.19 HKIAC 4.2(c) Guaranteed Obligations Section 9.17(b10.15(a) HK Subsidiary Preamble Indemnitee HSR Act Section 9.1(a4.2(c) Indemnifiable Loss Indemnified Party Section 9.1(a9.5 Indemnifying Party Section 9.5 Indemnity Escrow Account Section 2.2 Indemnity Escrow Agent Section 2.2 Indemnity Escrow Agreement Section 2.2 Indemnity Escrow Amount Section 2.2 Indemnity Escrowed Funds Section 2.2 Initial Working Capital Section 2.4 Inspection Section 6.4(a) Investor Preamble Investor’s Partners Latest Balance Sheet Section 8.17(b4.4(a) Key Employee Leases Section 4.22 Key Holders Preamble Lease 4.17(a) Limited Guarantees Section 4.7(b9.2(c) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 LLC Interests Recitals Material Contract Section 4.9 OFAC 4.10(b) Notice Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)9.5
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Documents Section 4.4(a10.02 Audited Balance Sheet Section 3.06(a) Associate Benefit Agreement Section 8.11 3.10(b) Benefit Plan Section 3.10(a) Business Recitals CFC Day Section 4.17(f10.02 Cash Section 1.04(f)(i) CES Credit Agreement Section 10.02 CES Credit Agreement Repayment Amount Section 6.11(a) Claim Threshold Section 9.06(a) Closing Section 3.1 1.02 Closing Cash Section 1.04(b) Closing Date Section 3.1 1.02 Closing Date Amount Section 1.04(a) Closing Indebtedness Section 1.04(b) Closing Working Capital Section 1.04(b) Code Section 4.17(f) 10.02 Company Preamble Company Intellectual Affiliate Section 10.11 Company Bylaws Section 3.01(b) Company Charter Section 3.01(b) Company Disclosure Letter Section 10.02 Company Employees Section 6.05(a) Company Financial Statements Section 3.06(a) Company Fundamental Representations Section 10.02 Company Insurance Policies Section 3.17 Company Leased Real Property Section 4.8(a3.08(b) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material 10.02 Company Owned Real Property Section 3.08(a) Company Personnel Section 3.10(i) Company Real Property Section 3.08(d) Company Real Property Lease Section 3.08(b) Company Required Regulatory Approval Section 3.05(b) Company Subsidiary Section 10.02 Confidentiality Agreement Section 6.01 Consent Section 2.03(b) Continuation Period Section 6.05(a) Contract Section 4.9 OFAC 2.03(a) Current Assets Section 4.18(a1.04(f)(ii) OFAC Sanctions Current Liabilities Section 4.18(a1.04(f)(iii) OFAC Sanctioned Person Term Section 4.18(bD&O Insurance Section 6.10(b) Ordinary Debt Financing Sources Section 10.02 Deductible Section 9.06(a) Definitive Financing Documentation Section 6.16(a) Easements Section 3.08(c) Environmental Laws Section 10.02 Environmental Permit Section 10.02 ERISA Section 3.10(a) ERISA Affiliate Section 3.10(a) Escrow Agent Section 1.05 Escrow Agreement Section 1.05 Escrow Amount Section 1.04(f)(iv) Escrow Fund Section 1.03(c) Estimated Cash Section 1.04(a) Estimated Indebtedness Section 1.04(a) Estimated Working Capital Section 1.04(a) Expiration Date Release Notice Section 9.07(a) Final Regulatory Order Section 10.02 Financing Section 4.05 Financing Action Section 6.16(a) Financing Commitment Section 4.05 Former Director Agreements Section 6.05(g) Fundamental Representations Section 10.02 GAAP Section 1.04(g) Good Utility Practice Section 10.02 Governmental Authorizations Section 3.14 Governmental Entity Section 2.03(b) Hazardous Substances Section 10.02 HSR Act Section 2.03(b) HSR Approval Section 6.02(a)(i) Indebtedness Section 1.04(f)(v) Indemnified Party Section 9.03(a) Indemnifying Party Section 9.03(a) Intangibles Section 3.16(a) Interim Balance Sheet Section 3.06(a) Judgment Section 2.03(a) Knowledge Section 10.02 Law Section 2.03(a) Liens Section 2.03(a) Losses Section 10.02 LTD and Retiree Medical Beneficiaries Section 6.05(b) Material Contracts Section 3.15(a) Net Adjustment Amount Section 1.04(f)(vi) NMGC Section 10.02 NMGC Credit Agreement Section 10.02 Term Section NMGC Credit Agreement Repayment Amount Section 6.11(b) NMGC Note Purchase Agreement Section 6.11(c) NMGC Notes Section 6.11(c) Notice of Disagreement Section 1.04(c) Order Section 10.02 Outside Date Section 8.01(b)(i) Permitted Liens Section 10.02 person Section 10.02 PNM Section 10.02 Projected Indemnity Amount Section 9.07(a) Purchase Price Section 1.01 Purchaser Preamble Purchaser Fundamental Representations Section 10.02 Purchaser Material Adverse Effect Section 4.01 Purchaser Required Regulatory Approval Section 4.03(b) Purchaser’s Indemnified Persons Section 9.01 Recoverable Insurance Claims Section 6.14 Regulatory Entity Section 3.19(a) Regulatory Permits Section 3.19(a) Regulatory Proceeding Section 3.19(b) Release Section 10.02 Representatives Section 6.16(b) Required Regulatory Approvals Section 4.03(b) Restricted Cash Section 1.04(f)(vii) Seller Preamble Seller Fundamental Representations Section 10.02 Seller Material Adverse Effect Section 2.01 Seller Required Regulatory Approval Section 2.03(b) Seller’s Indemnified Persons Section 9.02 Shares Preamble Statement Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g1.04(b) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Straddle Period Section 8.11 Restricted Share Agreement 9.01(d) subsidiary Section 6.1(f10.02 Survival Expiration Date Section 9.05(a) SDN List Target Working Capital Section 4.18(b1.04(f)(viii) Secretary Tax Section 4.18(a3.09(n) Series D Investor(sTax Returns Section 3.09(n) Recitals Series D Preferred Shares Recitals Series D Special Redemption Taxes Section 8.24 Series D Special Redemption Shareholder 3.09(n) Third Party Claim Section 8.24 Special Redemption Consideration Shares 9.03(a) Transactions Section 8.24 Special Redemption Price 1.01 Transfer Taxes Section 8.24 Subpart F Income 6.06 Voting Company Debt Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)3.03
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Balance Sheet Date Section 4.4(a3.6(a) Associate Book-Entry Shares Section 8.11 Business Recitals CFC 2.4(a) Certificates Section 4.17(f2.4(a) Chosen Courts Section 9.8 Closing Section 3.1 1.3 Closing Date Section 3.1 Code 1.3 COBRA Section 4.17(f3.9(c) Communications Laws Section 3.27 Company Preamble Company Intellectual Property Adverse Recommendation Change Section 4.8(a6.4(e) Company Owned Intellectual Property Balance Sheet Section 4.8(b3.6(a) Consideration Shares Company Board Recommendation Section 2.2 Constitutional Documents 6.2(b) Company Board Recommendation Notice Section 4.4(a6.4(g) Conversion Shares Section 2.5 Company Disclosure Schedule Section 4 Domestic 9.12 Company Preamble Equity Value of the Disqualified Persons Section 6.12(d) Company Employees Section 2.3(i6.12(a) FCPA Company Employee Plan Section 4.19 HKIAC 3.9(a) Company ERISA Affiliate Section 9.17(b3.9(a) HK Subsidiary Preamble Indemnitee Term Section 9.1(aCompany Financial Statements Section 3.6(a) Indemnifiable Loss Company Government Contract Section 9.1(a3.12(c) Investor Preamble Investor’s Partners Company Insiders Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 6.14 Company Material Contract Section 4.9 OFAC 3.12(a) Company Permits Section 4.18(a3.4(b) OFAC Sanctions Company SEC Reports Section 4.18(a3.5(a) OFAC Sanctioned Person Company Shareholder Approval Section 4.18(b3.3(b) Ordinary Company Shareholder Meeting Section 6.2(a) Company Voting Debt Section 3.2(g) Company Warrant Section 2.6(b) Confidential Information Section 3.15(j) Confidentiality Agreement Section 6.6(a) Department of State Section 1.4 Effective Time Section 1.4 Environmental Law Section 3.13 ERISA Section 3.9(a) Exchange Agent Section 2.4(a) Exchange Ratio Section 2.1(a) Excluded Shares Section 2.5 Personal Information 2.1(b) HSR Condition Section 4.30 PFIC 7.1(f) Indemnified Parties Section 4.17(g6.13(a) Public Software Insurance Policies Section 4.8(g3.17 In-the-Money Option Section 2.6(a) Purchased Shares In-the-Money SAR Section 2.1 Restriction 2.6(a) Leased Real Property Section 3.16(b) Legal Proceedings Condition Section 7.1(e) Measurement Date Section 4.2(a) Merger Recitals Merger Consideration Section 2.1(a) Merger Sub Preamble Merger Sub Documents Section 4.12(a) Notice Period Section 8.11 Restricted Share Agreement 6.4(h) Open Source Materials Section 6.1(f3.15(k) SDN List Parent Preamble Parent Balance Sheet Section 4.18(b4.7(a) Secretary Parent Disclosure Schedule Section 4.18(a9.12 Parent Financial Statements Section 4.7(a) Series D Investor(sParent Plans Section 6.12(b) Recitals Series D Preferred Shares Recitals Series D Special Redemption Parent Reports Section 8.24 Series D Special Redemption Shareholder 4.6(b) Parent Welfare Plan Section 8.24 Special Redemption Consideration Shares 6.12(b) Permitted Hires Section 8.24 Special Redemption Price 5.2(vi) Premium Cap Section 8.24 Subpart F Income 6.13(b) Proxy/Prospectus Section 8.17(b6.1(a) Transaction Documents Registration Statement Section 4.4(a6.1(a) UNCITRAL Rules Restraints Section 9.16(b7.1(d) United States Person Sxxxxxxx-Xxxxx Act Section 4.18(c3.5(b) WFOE Preamble Xunlei Group Term Section 8.5(b)SEC Condition Section 7.1(c) Statement of Merger Section 1.4
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Allocation Percentage Section 4.4(a1.4(a)(iii) Associate Alternate Debt Financing Section 8.11 5.12(a)(i) Assumed Employee Liabilities Section 1.9(c) Assumed Liabilities Section 1.9 Bankruptcy and Equity Exceptions Section 2.2 Bill of Sale and Assignment Agreement Section 1.3(a)(iv) Binder Agreement Section 4.14 Books and Records Section 1.7(g) Business Recitals CFC Leased Real Property Section 4.17(f3.6(b) Buyer Preamble Buyer Closing Failure Section 7.1(d)(ii) Buyer Confidential Information Section 5.21 Buyer Entities Preamble Buyer FSAs Section 5.4(h) Buyer Indemnified Persons Section 9.1(a) Buyer Parent Preamble Buyer Parent Class A Common Stock Section 4.4 Buyer Parent Class B Common Stock Section 4.4 Buyer Parent Common Stock Section 4.4 Buyer Parent Preferred Stock Section 4.4 Buyer Plans Section 5.4(b)(iii) Buyer Related Persons Section 7.2(c) Buyer Released Parties Section 10.2(a) Buyer Releasing Parties Section 10.2(a) Buyer Savings Plan Section 5.4(d) 102 Buyer SEC Documents Section 4.5(a) Buyer SEC Financial Statements Section 4.5(b) Buyer Tax Returns Section 8.1(b) Buy-Side Representations Section 10.1(e) Claim Date Section 9.2(a) Claim Notice Section 9.2(a) Closing Section 3.1 1.2 Closing Date Section 3.1 Code 1.2 Closing Delay Notice Section 4.17(f1.2 Commercial Agreements Section 1.3(e) Commitment Letters Section 4.11(a) Company Preamble Recitals Company Intellectual Property Related Persons Section 4.8(a7.2(c) Company Owned Intellectual Property Consent Required Contracts Section 4.8(b5.11(a) Consideration Continuation Period Section 5.4(b)(i) COVID-19 Relief Programs Section 3.23 Customer BA Agreement Section 3.14(h) D&O Costs Section 5.6(b) D&O Indemnifiable Claim Section 5.6(b) D&O Indemnifying Party Section 5.6(b) Debt Commitment Letter Section 4.11(a) Debt Financing Section 4.11(a) Dispute Notice Section 1.5(c) Disputed Items Section 1.5(c) Earnout Amount Section 5.19 Earnout Shares Section 2.2 Constitutional Documents 5.19 Employee Records Section 4.4(a1.7(k) Conversion Shares Section 2.5 Disclosure Equity Award Schedule Section 4 Domestic Company Preamble Equity Value of the Company 3.11(h) Estimated Closing Date Cash Section 2.3(i1.4(a)(i) Estimated Closing Date Indebtedness Section 1.4(a)(i) Estimated Net Working Capital Adjustment Amount Section 1.4(a)(i) Excluded Assets Section 1.8 Excluded IP Rights Section 1.8(h) Excluded IT Assets Section 1.8(i) FCPA Section 4.19 HKIAC 3.19 Fee Letter Section 9.17(b4.11(a) HK Subsidiary Preamble Filing Section 2.3(a) Final First Adjustment Amount Section 1.5(d) Final Second Adjustment Amount Section 1.6(d) Financial Statements Section 3.3(a) Financing Section 4.11(a) Financing Letters Section 4.11(a) First Adjustment Statement Section 1.5(a) First Review Period Section 1.5(b) Florida Company Commercial Agreement Amendment Section 1.3(c) Form D Approval Section 1.3(c) 103 FSA Participants Section 5.4(h) HSR Act Clearance Section 6.1(a) Indemnified Party Section 9.2(a) Indemnifying Party Section 9.2(a) Indemnitee Affiliates Section 9.1(a5.6(d) Indemnifiable Loss Independent Accountant Section 9.1(a1.5(c) Investor Preamble Investor’s Partners Legal Restraint Section 8.17(b6.1(b) Key Employee Liabilities Assumption Section 4.22 Key Holders Preamble Lease 1.1 Lock-Up Agreement Section 4.7(b1.3(a)(vii) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC 3.7(a) Material Customers Section 4.18(a3.7(a)(i) OFAC Sanctions Material Suppliers Section 4.18(a3.7(a)(ii) OFAC Sanctioned MHI Preamble Negative First Adjustment Amount Section 1.5(d) Negative Second Adjustment Amount Section 1.6(d) NIA Pennsylvania Section 5.23 Non-Florida Commercial Agreements Section 1.3(e) NYSE Section 4.2 Objection Notice Section 9.2(a) Outside Date Section 7.1(b)(i) Outstanding Buyer Common Shares Section 4.4 Parties Preamble Payment Statement Section 1.4(a) Personal Electronic Devices Section 1.8(q) Positive First Adjustment Amount Section 1.5(d) Positive Second Adjustment Amount Section 1.6(d) Post-Signing Insurance Proceeds Section 1.7(f) Pre-Closing Indemnified Person Section 4.18(b5.6(f) Ordinary Shares Pre-Closing Tax Refund Section 2.5 Personal 8.3 Preferred Equity Commitment Letter Section 4.11(a) Preferred Equity Financing Section 4.11(a) Preservation Date Section 5.8(a) Pre-Signing Buyer Reports Article IV Privacy Consents Section 3.5(m) Projections Section 10.1(c) Purchase Price Allocation Section 8.4 R&W Insurance Policy Section 4.14 Registration Rights Agreement Section 1.3(a)(v) Regulatory Concession Section 5.3(c) Replacement Award Section 5.4(c) Required Amount Section 4.11(c) Required Filings Section 2.3(b)(iii) Required Information Section 4.30 PFIC 5.12(b)(i) Restrictive Covenant Agreement Section 4.17(g1.3(a)(vi) Public Software Retained Liabilities Section 4.8(g1.10 Second Adjustment Statement Section 1.6(a) Purchased Shares Section 2.1 Restriction 104 Second Review Period Section 8.11 Restricted Share Agreement 1.6(b) Seller 401(k) Plan Section 6.1(f5.4(d) SDN List Seller FSAs Section 4.18(b5.4(h) Secretary Seller Indemnified Persons Section 4.18(a9.1(b) Series D Investor(sSeller Names Section 1.8(h) Recitals Series D Preferred Shares Recitals Series D Special Redemption Seller Parent Preamble Seller Released Parties Section 8.24 Series D Special Redemption Shareholder 10.2(b) Seller Releasing Parties Section 8.24 Special Redemption Consideration Shares 10.2(b) Seller Tax Returns Section 8.24 Special Redemption Price 8.1(a) Sellers Preamble Sell-Side Representations Section 8.24 Subpart F Income 10.1(c) Skadden Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)10.3
Appears in 1 contract
Samples: Stock and Asset Purchase Agreement (Evolent Health, Inc.)
Agreement Preamble. Ancillary Agreements Applicable Law 21.1.1 Auditor Attestation 21.4(b) Benchmarking 3.14 Billing Review 4.6.1 Provider Services Centers 2.2 Candidate 7.2 Catastrophic Failure 3.5.1(b) Change Proposal 2.5 Change Request 2.5 Claims 15.7(e) Commencement Date 3.1.1 Confidentiality Agreement Article 13 Confidential Information 13.1 Control 11.2.2(h) Customer Information 15.1(a) Data 15.1(b) Data Privacy and Security Laws 15.1(c) Dedicated Provider Personnel 7.1 Deliverables 3.10 Developer Tools 11.3.2 Disabling Code 16.7 Dispute 20.1 Dispute Commencement Date 20.1 Divested Entity 22.4.2 Effective Date Preamble Employee Information 15.1(d) Defined Term Section 4.4(a) Associate Section 8.11 Business Recitals CFC Section 4.17(f) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(f) Company Preamble Company in which Defined Exit Criteria Error! Reference source not found. Fees 4.1.1 FOIL 7.12 Force Majeure Event 22.14 Intellectual Property Rights 14.1 IT Laws 21.1.2 Key Provider Services Center Personnel 7.1 Losses 17.1 Milestones 2.2 New Services 2.6 Non-Operational 10.2 Object Code 5.1 the Agency Preamble the Agency Confidential Information 13.1 the Agency Data Article 15 the Agency’s Equipment and Facilities 9.1 the Agency Furnished Materials 14.4 Agency Affiliates Error! Reference source not found. the Agency Indemnitee 17.2.1 the Agency Marks 22.16 Agency Project Manager 8.1 the Agency Systems 14.6 Parent Company Error! Reference source not found. Performance Audit 4.7.1 Performance Failure 4.7.2 Permits 16.9 Personal Data 15.1(e) Pre-Existing Materials 14.5 Procedures Manual 2.4 Progress Report 3.8 Project Preamble Proposal 2.1 Related Company Error! Reference source not found. Residuals 14.8 Section 4.8(a404 21.4(a) Security Event 15.7(e) Service Levels 3.5.1(a) Service Level Credits 3.6.1 Service Level Matrix 3.5.1(a) Services Preamble Defined Term Section in which Defined Site 2.2 SOA 21.4(a) Source Code 5.1 SOW Services Commencement Date 2.2 Specifications 3.10 Scope of Work 2.2 Steering Committee 8.4 Step-In 3.6.3(c) Subsidiary Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Error! Reference source not found. Provider Preamble Equity Value Provider Confidential Information 13.1 Provider Personnel 7.1 Provider Project Manager 8.2 Temporary Extension of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Services 12.3 Term 11.1 Termination/Expiration Assistance 12.1 Termination/Expiration Assistance Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)12.1 Third Parties 3.3 Third Party Content 14.7 Third Party Technology 14.7
Appears in 1 contract
Samples: Master Services Agreement
Agreement Preamble. Ancillary Agreements Alternate Financing Section 4.4(a6.6(a) Associate Alternative Acquisition Agreement Section 8.11 Business Recitals CFC 6.4(d)(ii) Anti-Corruption Laws Section 4.17(f4.5(b) Articles of Merger Section 2.3 Bankruptcy and Equity Exception Section 4.3(a) Buyer Group Contracts Section 5.12 Certificates Section 3.2(b) claim Section 5.9 Closing Section 3.1 2.2 Closing Date Section 3.1 Code 2.2 Company Preamble Company Adverse Recommendation Change Section 4.17(f6.4(d)(i) Company Preamble Board Recitals Company Financial Advisor Section 4.3(b) Company Financial Statements Section 4.6(b) Company Group Section 8.2(f)(i) Company Intellectual Property Section 4.8(a4.14(b) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC 4.11(a) Company Preferred Stock Section 4.18(a4.2(a) OFAC Sanctions Company Recommendation Section 4.18(a4.3(b) OFAC Sanctioned Person Company Representatives Section 4.18(b6.3(a) Ordinary Company SEC Filings Section 4.6(a) Company Shareholders Meeting Section 6.2(e) Company Subsidiary Section 4.1 Cut-Off Date Section 6.4(b) D&O Insurance Section 6.12(b) debt Section 5.9 Debt Financing Section 5.6 Debt Financing Agreements Section 6.6(a) Debt Financing Commitment Letter Section 5.6 Dissenting Shares Section 2.5 Personal 3.1(a) Dissenting Shareholders Section 3.1(a) Effective Time Section 2.3 End Date Section 8.1(b)(i) Equity Financing Section 5.6 Equity Financing Commitment Letter Section 5.6 Exchange Fund Section 3.2(a) FBCA Recitals Fee Letter Section 5.6 Financing Section 5.6 Financing Commitment Letters Section 5.6 Guarantor Recitals Indemnified Parties Section 6.12(a) Investments Section 4.2(d) Lenders Section 5.6 Limited Guarantee Recitals Merger Recitals Merger Consideration Section 3.1(a) Merger Sub Preamble New Financing Documents Section 6.6(a) Parent Preamble Parent Expenses Section 8.2(d) Parent Group Section 8.2(f)(i) Parent Representatives Section 6.3(a) Party Preamble Paying Agent Section 3.2(a) Proxy Statement Section 6.2(a) Record Date Section 6.2(e)(ii) Required Financial Information Section 4.30 PFIC Section 4.17(g6.7(d) Public Software Section 4.8(g) Purchased Rollover Agreement Recitals Rollover Shares Section 2.1 Restriction 5.6 Schedule 13E-3 Section 6.2(b) SEC Reports Article IV Solicitation Period End Date Section 8.11 Restricted Share Agreement 6.4(a) Solvent Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)5.9
Appears in 1 contract
Samples: Agreement and Plan of Merger (China Fire & Security Group, Inc.)
Agreement Preamble. Ancillary Agreements Allocated Loan Amount Section 4.4(a1.10(a) Associate Allocated Loan Amounts Section 8.11 1.10(a) Anti-Terrorism Regulations Section 3.20(b) Application Section 1.02 Assessments Section 3.03(a) Assignment Section 1.10(b) Assignments Section 1.10(c) Award Section 3.08(b) Balance Section 1.03(a) Borrower Preamble Borrowers Preamble Business Recitals CFC Day Section 4.17(f1.04(b) Closing CMS Section 3.1 Closing 11.01(a)(ii) CHP Entity Section 5.01 CHP REIT Section 5.01 CON Section 11.01(a)(iii) Control, Controlled or Controlling Section 3.22 Costs Section 4.01 Creditors Rights Laws Section 3.22(y) Cross Collateral Assignment of Leases Section 1.10(d) Cross Collateral Assignments Section 1.10(e) Cross Collateral Documents Section 1.10(f) Cross Collateral Mortgage Section 1.10(g) Cross Collateral Mortgages Section 1.10(h) Daily Charge Section 1.04(a) Damage Section 3.07(a) Debt Service Coverage Ratio Section 3.10 Default Rate Section 1.04(b) Deposits Section 3.10(a) Discount Rate Section 1.06 Documents Section 1.02 Due Date Section 3.1 Code 1.03(c) Due Diligence Materials Section 4.17(f5.02(g) Company Preamble Company Intellectual Environmental Indemnity Section 1.10(i) Environmental Indemnities Section 1.10(j) Environmental Law Section 3.12(a) Environmental Liens Section 3.12(b) Prudential Loan Nos. 706109321 - 706109336 CNL BV Portfolio Amended and Restated Loan Agreement Environmental Report Section 3.12(a) ERISA Section 3.11(a) ERISA Indemnity Section 1.10(k) ERISA Indemnities Section 1.10(l) Escrow Agreement Section 1.10(m) Escrow Funds Section 10.04(a) Event of Default Section 6.01 Executive Order 13224 Section 2.09 FF&E Section 3.05(g) FHA Act Section 2.04(i) First Notice Section 3.15(c) Flood Acts Section 2.04(a) Full Replacement Cost Section 3.06(a) Funding Date Section 1.03(a) Governmental Authority Section 11.01(a)(iv) Grace Period Section 6.01(c) Hazardous Materials Section 3.12(a) Healthcare Laws Section 11.01(a)(v) Healthcare Permit Section 11.01(a)(vi) HIPAA Section 11.01(a)(vii) HIPAA Compliant Section 11.01(a)(viii) Impositions Section 3.10(a) Indemnified Parties Section 8.03 Indemnify Section 8.03 Individual Beneficiaries Section 2.09 Individual Loan Recitals, Section 4 Individual Loan Documents Section 1.02 Individual Property Section 4.8(a1.10(m) Company Owned Intellectual Property Individual Shareholders Section 4.8(b2.09 Insurance Premiums Section 3.10(a) Consideration Shares Instrument Section 2.2 Constitutional Documents 1.10(n) Instruments Section 4.4(a1.10(o) Conversion Shares Investors Section 2.5 Disclosure Schedule 9.06(a) Late Charge Section 1.04(a) Laws Section 3.05(c) Lender Preamble Lender Affiliates Section 9.10 Lien Section 1.10(p) LLC Agreement Section 3.22(x) Loan Recitals, Section 4 Domestic Company Preamble Equity Loan to Value of the Company Ratio Section 2.3(i5.02 Losses Section 8.03 Manager Paid Amount Section 10.04(d) FCPA Maturity Section 4.19 HKIAC 1.03(d) Maturity Date Section 9.17(b1.03(d) HK Subsidiary Preamble Indemnitee MBA Form Section 9.1(a3.06(d) Indemnifiable Loss Medicaid Section 9.1(a11.01(a)(ix) Investor Preamble Investor’s Partners Medicare Section 8.17(b11.01(a)(x) Key Employee Member Section 4.22 Key Holders Preamble Lease 3.22(x) Prudential Loan Nos. 706109321 - 706109336 CNL BV Portfolio Amended and Restated Loan Agreement Microbial Matter Section 4.7(b3.12(a) Licenses Net Proceeds Section 4.8(e3.07(d) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei NOI Section 2.3(ii3.10 Note Section 1.10(q) Material Adverse Effect Notes Section 4.1 Material Contract 1.10(r) Note Rate Section 4.9 1.03(a) Notice Section 9.02 NRS Section 10.04(c) O&M Plan Section 3.12(b) Obligations Section 1.01 OFAC Section 4.18(a2.09 OFAC Indemnity Section 8.01(a) OFAC Sanctions Lists Section 4.18(a2.09 OFAC Violation Section 3.20(c) OFAC Sanctioned Person Operator Section 4.18(b1.10(s) Ordinary Shares Operators Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g1.10(t) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Operator’s Sole Shareholder Section 8.24 Special Redemption Consideration Shares 2.05 Organization State Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)2.01
Appears in 1 contract
Agreement Preamble. Ancillary Alliance Manager Section 3.3(a) Arbitral Decision Section 14.2(b) Claims Section 12.1 Clinical Agreement Section 5.4 Commercialization Plan Section 6.2 Common Stock Section 8.3 Company Preamble CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Definition Reference Company Board Section 11.6(c) Company Development Activities Section 5.4 Company Development Expenses Section 5.7(a) Company Indemnitees Section 12.1 Confidential Information Section 11.1 Co-Promotion Agreement Section 6.6 Co-Promotion Right Section 6.6 DoJ Section 16.19(a) Effective Date Section 14.1 Exchange Act Section 11.4(c) Execution Date Preamble Existing Inventory Section 7.3(a) Existing Regulatory Documentation Section 13.2(k) Existing Study Section 5.3(a) Facility Section 7.1(b) *** Section 5.3(a) FTC Section 16.19(a) Generic Market Data Section 8.7(c)(i(3) HSR Conditions Section 16.19(b) IMMU-132 Information Section 11.1 Indemnitee Section 12.3 Indemnitor Section 12.3 JCC Section 3.2 JDC Section 3.2 Joint Inventions Section 10.1 Joint Patents Section 10.3(c) JPC Section 3.2 JSC Section 3.1(a) Legal Proceeding Section 16.20 Letter Agreement Section 16.6 Licensee Preamble Licensee Indemnitees Section 12.2 Licensee Xxxx(s) Section 14.5(d) Losses Section 12.1 Manufacturing Agreements Section 4.4(a7.3(d) Associate Marks Section 8.11 Business Recitals CFC 10.8(a) Match Period Section 4.17(f11.6(b) Closing Milestone Event Section 3.1 Closing 8.4 New Affiliate Date Section 3.1 Code 2.11 No-Shop Start Date Section 4.17(f11.6(a) Company NSCLC Section 5.3(a) Other Licensed Molecule Section 2.10 Other Royalty Term Section 8.7(b)(ii) CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Definition Reference Parties Preamble Company Intellectual Property Party Preamble Product Infringement Section 4.8(a10.4(a) Company Owned Intellectual Property Publication Section 4.8(b) Consideration 11.5 Purchased Shares Section 2.2 Constitutional Documents 8.3 Qualifying Sublicensee Section 4.4(a8.2(a) Conversion Shares *** *** ROFN Election Notice Section 2.5 Disclosure Schedule 2.9 ROFN Notice Section 4 Domestic Company Preamble Equity Value 2.9 ROFN Product Section 2.9 Sale of the Company Proposal Section 2.3(i11.6(c) FCPA SCLC Section 4.19 HKIAC 5.3(a) Sole Inventions Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)10.1
Appears in 1 contract
Samples: Development and License Agreement (Immunomedics Inc)
Agreement Preamble. Ancillary Agreements Defined Term Section 4.4(aAssumed Option Section 1.7(b) Associate Assumed RSU Section 8.11 Business 1.7(c) Auditor Section 4.6 Author Section 2.8(e) CAN-SPAM Section 2.8(a)(xiv) CCPA Section 2.8(a)(xiv) CICA Recitals CFC Class A Common Payment Shares Section 4.17(f1.5(b) Closing Section 3.1 1.3(a) Closing Date Section 3.1 Code 1.3(a) Collective Bargaining Agreement Section 4.17(f2.10(a)(v) Company Preamble Company Intellectual Property Acquisition Section 4.8(a4.4(a) Company Board Recitals Company Board Approval Recitals Company Board Recommendation Recitals Company Data Section 2.8(a)(i) Company Financial Statements Section 2.4(a) Company Material Contracts Section 2.10(a) Company Officers Certificate Section 7.6 Company Owned Intellectual Property Section 4.8(b2.8(a)(ii) Consideration Company Permits Section 2.11(b) Company Privacy Commitments Section 2.8(m) Company Privacy Policies Section 2.8(a)(iii) Company Products Section 2.8(a)(iv) Company Registered Intellectual Property Section 2.8(a)(v) Company Related Parties Section 9.2(b) Company Shareholder Matters Section 5.1(a) Company Shareholder Meeting Section 5.1(b) Company Virtual Data Room Section 10.12(h) Company Voting Agreement Recitals Company Websites Section 2.8(a)(vi) Confidential Information Section 2.8(f) Convertible Preferred Payment Shares Section 2.2 Constitutional 1.5(b) D&O Indemnified Persons Section 5.6(a) Designated Director Section 5.12 Dissenting Shareholders Section 1.11(a) Dissenting Shares Section 1.11(a) Embargoed Countries Section 2.12 End Date Section 9.1(b) Exchange Agent Section 1.10(a) Exchange Fund Section 1.10(a) Expense Reimbursement Section 9.2(a) Export Approvals Section 2.12 FCPA Section 2.13 Final Consideration Spreadsheet Section 5.11 First Effective Time Section 1.3(b) First Merger Recitals First Merger Filing Documents Section 4.4(a1.3(b) Conversion Shares First Plan of Merger Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b1.3(b)
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Nuvation Bio Inc.)
Agreement Preamble. Ancillary Agreements Section 4.4(aAllocation 1.16 Arbitration Firm 1.7(c)(ii)(3) Associate Section 8.11 Business Recitals CFC Section 4.17(fAudited Financial Statements 2.7(a) Buyer Benefit Plans 6.6(b) Certificate of Merger 1.4 Closing 1.3 Closing Date 1.3 Closing Date Payees 1.7(b)(iv) Closing Section 3.1 Closing Date Section 3.1 Code Section 4.17(fStatement 1.7(a) COBRA 2.17(e) Commitment Letters 3.6 Company Preamble Company Continuing Employee 6.6(a) Company Employee Plan 2.17 Company Registered Intellectual Property Section 4.8(a2.14(a) Company Owned Intellectual Property Section 4.8(bUnit Certificate 1.10(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Covered Matter 9.7 Debt Commitment Letter 3.6 Disclosure Schedule Section 4 Domestic Company Preamble 2 Disclosure Supplement 5.1 Divestiture Action 4.10(c) Effective Time 1.4 Environmental Laws 2.21 Environmental Liabilities 2.21 Equity Value Commitment Letter 3.6 Escrow Deposit Amount 1.7(b)(v) Escrow Funds 1.7(b)(iii) Estimated Working Capital 1.7(c)(i) Estimated Working Capital Overage 1.7(c)(i) Estimated Working Capital Statement 1.7(c)(i) Estimated Working Capital Underage 1.7(c)(i) Exercise Number 1.9(a) Existing NDA 10.14 Final Allocation 1.16 Final Determination Date 1.7(c)(ii)(4)(a) Final Working Capital 1.7(c)(ii)(1) Final Working Capital Excess 1.7(c)(ii)(4)(b) Final Working Capital Shortfall 1.7(c)(ii)(4)(a) Term Section Financial Statements 2.7(a) FIRPTA Certificate 1.13 Forward-Looking Statements 5.2 Guaranteed Obligations 10.16 Hazardous Materials 2.21 Health Privacy Laws 2.24(b) HIPAA 2.24(b) Insurance Policies 2.15 Interested Party 2.20(a) Interim Financial Statements 2.7(a) IT Systems 2.14(m) Letter of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(iiTransmittal 1.10(b) Material Adverse Effect Section Contract 2.13(a) Material IP Agreements 2.13(a)(x) Member Written Consent Recitals Merger Recitals Merger Consideration 1.6(b) Merger Sub Preamble Most Recent Balance Sheet 2.7(a) New Matter 5.1 Option Additional Consideration 1.9(a) Option Closing Consideration 1.9(a) Option Consideration 1.9(a) Parent Preamble Parent Press Release 4.7 Payments Administrator 1.10(a) Payments Administrator Agreement 1.10(a) Permits 2.16 Pre-Closing Period 4.1 Material Contract Section 4.9 OFAC Section 4.18(aPre-Closing Tax Return 6.7(a)(i) OFAC Sanctions Section 4.18(aReal Property 2.10 Representative Losses 10.15(f) OFAC Sanctioned Person Section 4.18(bRequisite Member Approval 2.2 Rights Agreements 2.4(d) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(gSecurityholder Representative Retention Account 10.15(e) Public Software Section 4.8(gSecurityholder Representative Retention Amount 10.15(e) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(fSecurityholder Tax Matter 6.7(c)(ii) SDN List Section 4.18(b) Secretary Section 4.18(aSecurity Incident 2.14(m) Series D Investor(s1 Per Unit Merger Consideration 1.8(d)(i) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Term Section
Appears in 1 contract
Samples: Escrow Agreement (Resmed Inc)
Agreement Preamble. Ancillary Agreements Assignment and Assumption Agreement Section 4.4(a5.2(b) Associate Assignment of Equity Interests Section 8.11 Business Recitals CFC 5.2(g) Assumed Liabilities Section 4.17(f2.1 Auditor Section 3.3 Xxxx of Sale and Assignment Section 5.2(a) Buyer Preamble Buyer Benefit Plans Section 9.4(d) Buyer Disclosure Letter Article VIII Buyer Indemnified Parties Section 12.2(a) Buyer Indemnified Party Section 12.2(a) Buyer Permits Section 8.6 Buyer Related Parties Section 8.5 Buyers’ 125 Plan Section 9.4(g) Buyer’s 401(k) Plan Section 9.4(f) Buyer’s Medical Plans Section 9.4(e) Cap Section 12.6(a) CEOC Preamble Chips and Tokens Section 2.1(i) CLC Section 7.7(a) Closing Section 3.1 5.1 Closing Date Section 5.1 Closing Payment Section 3.1 Code Commitment Letter Section 4.17(f8.4 Company Preamble Company’s 125 Plan Section 9.4(g) Company 401(k) Plan Section 9.4(f) Company Benefit Plans Section 7.13(a) Company Disclosure Letter Article VII Company Permits Section 7.11(a) Customer Deposits Section 4.4(c) Damages Section 12.2(a) Deductible Section 12.6(a) Defect Notice Section 13.2(a) Deposit Section 3.2 Deposit Escrow Agreement Section 3.2 79 Terms Cross Reference in Agreement Designated Buyer Representative Section 9.2(a) Determination Date Section 4.3(c) DOL Section 7.13(c) Effective Date Preamble Company Intellectual Endorsement Section 13.1 Environmental Authorizations Section 7.10 Equity Interests Recitals ERISA Section 7.13(a) Escrow Agent Section 3.2 Estimated Closing Payment Section 4.1 Estimated Closing Statement Section 4.1 Estimated Operations Payment Section 4.2 Estimated Operations Statement Section 4.2 Excluded Assets Section 1.2 Excluded Liabilities Section 2.2 Extension Deposit Section 3.2 FCC Approvals Section 9.14(a) Final Closing Payment Section 4.3(a) Final Closing Statement Section 4.3(a) Final Operations Payment Section 4.3(b) Final Operations Statement Section 4.3(b) Final Statements Section 4.3(c) Financial Information Section 7.3 Fundamental Representations Section 12.1(b) Governmental Approvals Section 9.6(a) Governmental Entity Section 6.2(c) Group Tax Returns Section 12.9(b)(i) HMHO Preamble HSR Act Section 6.2(c) Improvements Section 14.1(a) Indemnified Parties Section 12.3 Indemnified Party Section 12.3 Indemnifying Parties Section 12.3 Indemnifying Party Section 12.3 Inspection Section 9.5(a) Insurance Policies Section 7.20 Inventoried Vehicles Section 9.11(e) Labor Agreement Section 7.12(b) Make-Whole Amount Section 11.2(d) Monetary Defects Section 13.2(c) Multiemployer Plan Section 7.13(c) Multiple Employer Plan Section 7.13(c) New Sale Agreement Section 11.2(d) 80 Terms Cross Reference in Agreement Non-Assignable Excluded Asset Section 1.4(c) Non-Monetary Defect Section 13.2(a) Notice Section 12.3 Notice Period Section 13.2(a) Objection Notice Section 12.5(a) Ordinary Course of Business Section 14.1 Other Transferred Registered IP Section 7.7(a) Outside Date Section 5.1 Owned Real Property Section 4.8(a7.6(a) Company Owned Intellectual Payoff Letter Section 9.20 PMHN Preamble Pre-Closing Separate Tax Returns Section 12.9 Property Employees Section 4.8(b7.13(a) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Purchase Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)3.1
Appears in 1 contract
Samples: Equity Interest Purchase Agreement (CAESARS ENTERTAINMENT Corp)
Agreement Preamble. Ancillary Agreements Alternate Debt Financing Section 4.4(a6.6(a) Associate Alternative Acquisition Agreement Section 8.11 Business Recitals CFC 6.4(c) Bankruptcy and Equity Exception Section 4.17(f4.3(a) Cayman Companies Law Preamble Certificates Section 3.2(c) Closing Section 3.1 2.2 Closing Date Section 3.1 Code 2.2 Company Preamble Defined Term Section 4.17(fCompany Adverse Recommendation Change Section 6.4(c) Company Board Preamble Company Financial Advisor Section 4.3(b) Company Financial Statements Section 4.6(b) Company Group Section 8.2(f)(i) Company Intellectual Property Section 4.8(a4.14(b) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC 4.11(b) Company Plan(s) Section 4.18(a4.9(a) OFAC Sanctions Company Recommendation Section 4.18(a4.3(b) OFAC Sanctioned Person Company Representatives Section 4.18(b6.3(a) Ordinary Company SEC Filings Section 4.6(a) Company Shareholders Meeting Section 6.2(e)(i) Company Subsidiary Section 4.1 Company Workers Section 4.14(e) Debt Financing Section 5.6(a) Debt Financing Commitment Section 5.6(a) Dissenter Rights Section 3.1(e) Dissenting Shares Section 2.5 Personal Information 3.1(e) Dissenting Shareholders Section 4.30 PFIC 3.1(e) Effective Time Section 4.17(g2.3 Equity Financing Section 5.6(b) Public Equity Financing Commitments Section 5.6(b) End Date Section 8.1(b)(i) Exchange Fund Section 3.2(b) Fee Letter Section 5.6(c) Financing Section 5.6(b) Financing Commitments Section 5.6(b) Guarantor Preamble HKIAC Section 9.7(c) Indemnified Parties Section 6.12 Investments Section 4.2(d) Leased Real Property Section 4.17(b) Limited Guarantee Preamble Merger Preamble Merger Sub Preamble New Debt Financing Commitment Section 6.6(a) Notice Period Section 6.4(d)(iii) Owned Real Property Section 4.17(a) Parent Preamble Parent Group Section 8.2(f)(i) Defined Term Section Parent Representatives Section 6.3(a) Party Preamble Paying Agent Section 3.2(a) Per ADS Merger Consideration Section 3.1(b) Per Share Merger Consideration Section 3.1(b) Plan of Merger Section 2.3 Proprietary Software Section 4.8(g4.14(h) Purchased Proxy Statement Section 6.2(a) Registrar of Companies Section 2.3 Rollover Securities Preamble SAFE Rules and Regulations Section 4.5(b) Schedule 13E-3 Section 4.4(b) Special Committee Preamble Support Agreement Preamble Surviving Company Section 2.1 Transactions Preamble Transaction Litigation Section 6.9 Uncertificated Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b3.2(c)
Appears in 1 contract
Samples: Agreement and Plan of Merger (iDreamSky Technology LTD)
Agreement Preamble. Ancillary Agreements Allocated Loan Amount Section 4.4(a1.10(a) Associate Allocated Loan Amounts Section 8.11 1.10(a) Anti-Terrorism Regulations Section 3.20(b) Application Section 1.02 Assessments Section 3.03(a) Assignment Section 1.10(b) Assignments Section 1.10(c) Award Section 3.08(b) Balance Section 1.03(a) Borrower Preamble Borrowers Preamble Business Recitals CFC Day Section 4.17(f1.04(b) Closing CMS Section 3.1 Closing 11.01(a)(ii) CHP Entity Section 5.01 CHP REIT Section 5.01 CON Section 11.01(a)(iii) Control, Controlled or Controlling Section 3.22 Costs Section 4.01 Creditors Rights Laws Section 3.22(y) Cross Collateral Assignment of Leases Section 1.10(d) Cross Collateral Assignments Section 1.10(e) Cross Collateral Documents Section 1.10(f) Cross Collateral Mortgage Section 1.10(g) Cross Collateral Mortgages Section 1.10(h) Daily Charge Section 1.04(a) Damage Section 3.07(a) Debt Service Coverage Ratio Section 3.10 Default Rate Section 1.04(b) Deposits Section 3.10(a) Discount Rate Section 1.06 Documents Section 1.02 Due Date Section 3.1 Code 1.03(c) Due Diligence Materials Section 4.17(f5.02(g) Company Preamble Company Intellectual Environmental Indemnity Section 1.10(i) Environmental Indemnities Section 1.10(j) Environmental Law Section 3.12(a) Environmental Liens Section 3.12(b) Environmental Report Section 3.12(a) Prudential Loan Nos. 706109321 - 706109336 and 706109394 CNL BV Portfolio Second Amended and Restated Loan Agreement ERISA Section 3.11(a) ERISA Indemnity Section 1.10(k) ERISA Indemnities Section 1.10(l) Escrow Agreement Section 1.10(m) Escrow Funds Section 10.04(a) Event of Default Section 6.01 Executive Order 13224 Section 2.09 Existing Borrowers Recitals, Section 1 Existing Loan Agreement Recitals, Section 1 Existing Loans Recitals, Section 1 FF&E Section 3.05(g) FHA Act Section 2.04(i) First Notice Section 3.15(c) Flood Acts Section 2.04(a) Full Replacement Cost Section 3.06(a) Funding Date Section 1.03(a) Governmental Authority Section 11.01(a)(iv) Grace Period Section 6.01(c) Hazardous Materials Section 3.12(a) Healthcare Laws Section 11.01(a)(v) Healthcare Permit Section 11.01(a)(vi) HIPAA Section 11.01(a)(vii) HIPAA Compliant Section 11.01(a)(viii) Impositions Section 3.10(a) Indemnified Parties Section 8.03 Indemnify Section 8.03 Individual Beneficiaries Section 2.09 Individual Loan Recitals, Section 4 Individual Loan Documents Section 1.02 Individual Property Section 4.8(a1.10(m) Company Owned Intellectual Property Individual Shareholders Section 4.8(b2.09 Insurance Premiums Section 3.10(a) Consideration Shares Instrument Section 2.2 Constitutional Documents 1.10(n) Instruments Section 4.4(a1.10(o) Conversion Shares Investors Section 2.5 Disclosure Schedule 9.06(a) Late Charge Section 1.04(a) Laws Section 3.05(c) Lender Preamble Lender Affiliates Section 9.10 Lien Section 1.10(p) LLC Agreement Section 3.22(x) Loan Recitals, Section 4 Domestic Company Preamble Equity Loan to Value Ratio Section 5.02 Losses Section 8.03 Manager Paid Amount Section 10.04(d) Maturity Section 1.03(d) Maturity Date Section 1.03(d) MBA Form Section 3.06(d) Medicaid Section 11.01(a)(ix) Medicare Section 11.01(a)(x) Prudential Loan Nos. 706109321 - 706109336 and 706109394 CNL BV Portfolio Second Amended and Restated Loan Agreement Member Section 3.22(x) Microbial Matter Section 3.12(a) Net Proceeds Section 3.07(d) NOI Section 3.10 Note Section 1.10(q) Notes Section 1.10(r) Note Rate Section 1.03(a) Notice Section 9.02 NRS Section 10.04(c) O&M Plan Section 3.12(b) Obligations Section 1.01 OFAC Section 2.09 OFAC Indemnity Section 8.01(a) OFAC Lists Section 2.09 OFAC Violation Section 3.20(c) Operator Section 1.10(s) Operators Section 1.10(t) Operator’s Sole Shareholder Section 2.05 Organization State Section 2.01 Owner Section 1.10(u) Owners Section 1.10(v) Owner’s Sole Member Section 2.05 PCBs Section 3.12(a) Permits Section 11.01(a)(xi) Permitted Capital Leases Section 11.02(h) Permitted Encumbrances Section 2.01 Permitted Transfer Section 5.01 Permitted Transfers Section 5.01 Pool Obligations Section 1.10(w) Prepayment Premium Section 1.06 Present Value of the Company Loan Section 2.3(i1.06 Property Section 1.10(x) FCPA Property Payables Section 4.19 HKIAC 3.09 Property State Section 9.17(b2.01 Provider Section 11.02(b)(iii) HK Subsidiary Preamble Indemnitee PTE Section 9.1(a3.11(a) Indemnifiable Rating Agency Section 9.06(a) Recourse Documents Section 1.10(y) Recourse Guarantor Section 1.10(z) Recourse Liabilities Guaranty Section 1.10(aa) Recourse Liabilities Guaranties Section 1.10(bb) Recourse Parties Section 8.01 Release Section 3.12(a) Rent Loss Proceeds Section 9.1(a3.07(c) Investor Preamble Investor’s Partners Rent Roll Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) 2.11 Replacement Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f10.04(e) SDN List Replacement Manager Section 4.18(b3.29 Replacement Manager Term Sheet Section 3.29 Resident Agreements Section 11.01(a)(xii) Secretary Restoration Section 4.18(a3.07(a) Series D Investor(sPrudential Loan Nos. 706109321 - 706109336 and 706109394 CNL BV Portfolio Second Amended and Restated Loan Agreement Revenue Code Section 2.05 Second Notice Section 3.15(c) Recitals Series D Preferred Shares Recitals Series D Securities Section 9.06(a) Security Agreement Section 7.01 Senior Living Facility Exhibit B Special Redemption Member Section 8.24 Series D Special Redemption Shareholder 3.22(x) Supplemental Guaranty Recitals, Section 8.24 Special Redemption Consideration Shares 8 Supplemental Loan Section 8.24 Special Redemption Price 5.02 Supplemental Loan Debt Service Coverage Ratio Section 8.24 Subpart F Income 5.02 Supplemental Loan NOI Section 8.17(b5.02 Supplemental Standby Fee Section 5.02(e) TADS Section 3.10 Taking Section 3.08(a) Tenant Recovery Section 3.25 Third Party Payor Section 11.01(a)(xiii) Third Party Payor Programs Section 11.01(a)(xiv) Transaction Documents Taxes Section 4.4(a3.03(c) UNCITRAL Rules Treasury Rate Section 9.16(b1.06 TRICARE Section 11.01(a)(xv) United States Person Trustee Recitals, Section 4.18(c6 U.C.C. Section 2.02 Violation Section 3.11(c) WFOE Preamble Xunlei Group Section 8.5(bPrudential Loan Nos. 706109321 - 706109336 and 706109394 CNL BV Portfolio Second Amended and Restated Loan Agreement SECOND AMENDED AND RESTATED LOAN AGREEMENT THIS SECOND AMENDED AND RESTATED LOAN AGREEMENT (this “Agreement”) is made as of the 3rd day of March, 2014, by and between each of the entities listed on Schedule A attached hereto, each having its principal office and place of business as shown on Exhibit E attached hereto (each of the foregoing entities is referred to individually as a “Borrower” and collectively as “Borrowers”), and THE PRUDENTIAL INSURANCE COMPANY OF AMERICA, a New Jersey corporation, having an office at c/o Prudential Asset Resources, Inc., 0000 Xxxx Xxxxxx, Suite 2500, Dallas, Texas 75201, Attention: Asset Management Department; Reference Loan Nos. 706109321—706109336 and 706109394, as lender (“Lender”).
Appears in 1 contract
Agreement Preamble. All Risks Preamble All Risks Interests Recitals All Risks Shares Recitals Allocation Schedule Section 8.01(f)(iii) Alternative Financing Section 5.13(a) AmRisc Section 9.05(c) Ancillary Agreements Section 4.4(a9.05(c) Associate Balance Sheet Section 8.11 3.05(a) Balance Sheet Date Section 3.05(a) Benefit Plan Section 3.18(a) Binding Authority Section 9.05(c) Bonus Pool Section 9.05(c) Bonus Pool Taxes Amount Section 9.05(c) Broker Section 9.05(c) Business Recitals CFC Broker Section 4.17(f9.05(c) Business Carrier Section 9.05(c) Business Day Section 9.05(c) Contract Section 2.03 Conversion Section 8.01(f)(i) Conversion Documentation Section 8.01(f)(i) Converted Company Section 8.01(f)(i) Convertible Securities Section 9.05(c) Core Ancillary Agreement Section 9.05(c) Cortezi Rollover Amount Section 9.05(c) Carrier Section 9.05(c) Cash Section 9.05(c) Casualty Proceeds Section 9.05(c) Certain Counterparties Section 5.07(b) Change of Control Payment Section 9.05(c) Closing Section 3.1 1.02 Closing Cash Section 9.05(c) Closing Date Section 3.1 1.02 Closing Date Amount Section 1.03(b)(i) Closing Indebtedness Section 9.05(c) Code Section 4.17(f9.05(c) Commitment Letters Section 4.06 Companies Preamble Companies’ Fundamental Representations Certificate Section 6.02(a) Companies’ Non-Fundamental Representations Certificate Section 6.02(a) Company Preamble Company Contracts Section 3.12(b) Company Data Section 3.10(b) Company Group Section 9.05(c) Company Intellectual Property Section 4.8(a3.09(a) Company IT Systems Section 3.10(a) Company Material Adverse Effect Section 9.05(c) Company Returns Section 3.15(a) Company Subsidiary Section 9.05(c) Competitive Activities Section 5.11(a)(i) Confidentiality Agreement Section 5.04(a) Consent Section 2.03 Final Bonus Pool Taxes Amount Section 1.04(c) Final Closing Indebtedness Section 1.04(c) Final Seller Transaction Expenses Section 1.04(c) Final Working Capital Section 1.04(c) Finance Contracts Section 9.05(c) Financing Section 4.06 Financing Sources Section 9.05(c) Fraud Section 9.05(c) FTC Section 5.05(c) Fundamental Representations Section 9.05(c) Covered Claim Section 9.11 Covered Employee Section 5.07(b) Creditors Section 1.04(a) Current Assets Section 1.04(g) Current Liabilities Section 1.04(g) Cyber Premium Amount Section 1.03(a)(xi) Debt Commitment Letter Section 4.06 DOJ Section 5.05(c) DRE Election Section 8.01(f)(i) Earliest Closing Date Section 1.02 Employment Agreements Section 6.02(f) Environmental Laws Section 9.05(c) Equity Commitment Letter Section 4.06 Equity Interests Recitals Equity Purchase Agreements Recitals ERISA Section 3.18(a) ERISA Affiliate Section 9.05(c) Estimated Closing Cash Section 1.04(a) Estimated Closing Indebtedness Section 1.04(a) Estimated Seller Transaction Expenses Section 1.04(a) Estimated Working Capital Section 1.04(a) Exchange Act Section 9.05(c) Family Section 9.05(c) Filing Section 2.03 Interim Financial Statements Section 3.05(a) Judgment Section 9.05(c) Knowledge Section 9.05(c) Law Section 9.05(c) Leased Property Section 3.08(a) Lien Section 9.05(c) Loss Section 9.05(c) Lost Premium Section 5.07(b) Make-Whole Compensation Section 5.07(b) Material Interest Section 9.05(c) Materiality Scrape Exceptions Section 9.05(c) Maximum Cash Amount Section 9.05(c) Fundamental Representations Certificates Section 6.02(a) GAAP Section 9.05(c) Government Agency Section 5.11(a)(iii) Governmental Entity Section 2.03 Hazardous Materials Section 9.05(c) HSR Act Section 2.03 ICS Preamble ICS Equity Interests Recitals Identified Long-Term Incentive Plan Credit Section 9.05(c) Identified Long-Term Incentive Plans Section 9.05(c) Identified Long-Term Incentive Plans Spreadsheet Section 9.05(c) including Section 9.05(c) Indebtedness Section 9.05(c) Indemnified Party Section 8.06(a) Indemnifying Party Section 8.06(a) Insured Section 9.05(c) Intellectual Property Section 9.05(c) Intended Tax Treatment Section 8.01(f)(ii) Principal Preamble Privacy Policy(ies) Section 9.05(c) Privacy Requirements Section 9.05(c) Pro Rata Share Section 9.05(c) Proceeding Section 9.05(c) Process Section 9.05(c) Processed Section 9.05(c) Processing Section 9.05(c) Producer Section 9.05(c) Producer Contracts Section 9.05(c) Property Taxes Section 8.01(a)(ii) Proprietary Software Section 3.09(d)(i) Purchase Price Section 1.01 Purchaser Preamble Purchaser Financial Statements Section 4.09(a) Purchaser Fundamental Representations Section 9.05(c) Purchaser Indemnitees Section 9.05(c) Purchaser Material Adverse Effect Section 9.05(c) New Commitment Letter Section 5.13(a) Xxxxxxx Preamble Noncompetition Period Section 5.11(a) Non-Fundamental Representations Certificates Section 6.02(a) Notice Section 5.07(a) Notice of Disagreement Section 1.04(c) Open Source Code Section 9.05(c) Ordinary Course of Business Section 9.05(c) Other Bid Section 5.02 Outside Date Section 7.01(a)(ii) Owned Intellectual Property Section 4.8(b3.09(a) Consideration Shares Permits Section 2.2 Constitutional Documents 3.13 Permitted Lien Section 4.4(a9.05(c) Conversion Shares Person Section 2.5 Disclosure Schedule 9.05(c) Personal Information Section 4 Domestic Company 9.05(c) Personnel Section 3.09(c) Policy Section 9.05(c) Pre-Closing Refund Section 9.05(c) Pre-Closing Taxes Section 9.05(c) Restrictive Covenant Agreements Section 6.02(f) Retail Broker Section 9.05(c) Reverse Termination Fee Section 7.02(b) Rollover Agreements Recitals Rollover Transactions Recitals Securities Act Section 3.27 Seller Preamble Equity Value of the Company Seller Indemnitees Section 2.3(i8.03(a)(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Seller Material Adverse Effect Section 4.1 Material Contract 9.05(c) Seller Tax Matter Section 4.9 OFAC 9.05(c) Seller Transaction Expenses Section 4.18(a9.05(c) OFAC Sanctions Sellers Preamble Sellers’ Fundamental Representations Certificate Section 4.18(a6.02(a) OFAC Sanctioned Sellers’ Non-Fundamental Representations Certificate Section 6.02(a) Sellers’ Representative Section 1.05(a) Skip Xxxx CA Preamble Skip Xxxx Entities Preamble Skip Xxxx MD Preamble Software Section 9.05(c) Solvent Section 4.10 Specified Persons Section 7.02(c) Statement Section 1.04(b) Straddle Period Section 9.05(c) Qualified Benefit Plan Section 3.18(d) R&W Policy Section 9.05(c) Xxxxxx Section 2.06 Real Property Leases Section 3.08(a) Records Section 5.10 Registered Intellectual Property Section 3.09(a) Related Person Section 4.18(b9.05(c) Ordinary Shares Release Section 2.5 Personal Information 9.05(c) Released Claims Section 4.30 PFIC 8.08 Releasee Section 4.17(g8.08 Releasees Section 8.08 Representative Section 9.05(c) Public Software Subject Materials Section 4.8(g8.06(c) Purchased Shares Subsidiary Section 2.1 Restriction Period 9.05(c) Target Working Capital Section 8.11 Restricted Share 1.01(h) Tax Section 9.05(c) Tax Return Section 9.05(c) Tax Sharing Agreement Section 6.1(f9.05(c) SDN Taxes Section 9.05(c) Technology Section 9.05(c) Third Party Claim Section 8.06(a) Transactions Section 1.01 Transfer Taxes Section 9.05(c) Trust 1 Recitals Trust 2 Recitals Trust Seller Preamble Trust Sellers Preamble Underwriting Business Section 9.05(c) Voting Debt Section 9.05(c) WARN Section 9.05(c) WARN Act List Section 4.18(b5.14 Wholesale Broker Section 9.05(c) Secretary Wholesale Brokerage Business Section 4.18(a9.05(c) Series D Investor(sWillful Breach Section 9.05(c) Recitals Series D Preferred Shares Recitals Series D Special Redemption Willfully Breached Section 8.24 Series D Special Redemption Shareholder 9.05(c) Working Capital Section 8.24 Special Redemption Consideration Shares 1.04(g) EQUITY PURCHASE AGREEMENT This EQUITY PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of June 23, 2020, among Xxxx Xxxxxxx (“Principal”), in his individual capacity and in his capacity as the Sellers’ Representative, the Persons named on Exhibit A (each, a “Trust Seller” and, collectively, “Trust Sellers” and, together with Principal, each, a “Seller” and, collectively, “Sellers”), All Risks, LTD, a Maryland corporation (“All Risks”), Independent Claims Services, LLC, a Maryland limited liability company (“ICS” and together with All Risks, each a “Company” or together, the “Companies”), Skipjack Premium Finance Company, a Maryland corporation (“Skip Xxxx MD”), Skipjack Premium Finance Company, a California corporation (“Skip Xxxx CA”, and together Skip Xxxx MD, the “Skip Xxxx Entities”) for purposes of Article V and Section 8.24 Special Redemption Price 8,08 only, Xxxxxxx Xxxxxxx (“Xxxxxxx”) for purposes of Article III, Section 8.24 Subpart F Income 6.02(a) and Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b8,03 only, and Xxxx Specialty Group, LLC, a Delaware limited liability company (“Purchaser ”).
Appears in 1 contract
Samples: Equity Purchase Agreement (Ryan Specialty Group Holdings, Inc.)
Agreement Preamble. Ancillary Agreements Section 4.4(aBenefit Plans 1.1 Board Recommendation 5.22 Book Entry Shares 1.1 Business Day 1.1 Certificate of Merger 3.2 Certificates 4.1(c) Associate Section 8.11 Business Recitals CFC Section 4.17(fChange of Recommendation 7.3(d) Cleanup 1.1 Closing Section 3.1 3.3 Closing Date Section 3.1 3.3 Code Section 4.17(f) 1.1 Company Preamble Company Intellectual Property Section 4.8(aArrangements 5.9(h) Company Owned Intellectual Property Section 4.8(bBalance Sheet 5.6 Company Balance Sheet Date 1.1 Company Common Stock 1.1 Company Compensation Committee 5.9(h) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Company Disclosure Schedule Section 4 Domestic 1.1 Company Preamble Equity Value of the Plans 1.1 Company Section 2.3(iFinancial Advisor 5.23 Company Financial Statements 5.5(b) FCPA Section 4.19 HKIAC Section 9.17(bCompany License-In Agreements 5.12(b) HK Subsidiary Preamble Indemnitee Section 9.1(aCompany License-Out Agreements 5.12(c) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Company Material Adverse Effect Section 4.1 1.1 Company Measurement Price 1.1 Company Performance Restricted Stock Award 1.1 Company Products 1.1 Company Real Property 5.14(a) Company Related Party 1.1 Company Restricted Stock Award 1.1 Company SEC Reports 5.5(a) Company Stock Option 1.1 Company Warrants 1.1 Confidentiality Agreement 1.1 Consideration Fund 4.2(a) Contract 1.1 Converted PRSU 4.3(d) Converted RSUs 4.3(b) Covered Securityholders 5.9(h) D&O Indemnitee 7.6(a) D&O Insurance 7.6(b) DGCL 1.1 Disclosure Document 1.1 Effective Time 3.2 Employees 7.4(a) Environmental Claim 1.1 Environmental Laws 1.1 ERISA 1.1 ERISA Affiliate 1.1 ESPP 1.1 Exchange Act 1.1 Exchange Agent 4.2(a) Exchange Ratio Recitals Expiration Date 2.1(c) FCPA 1.1 Financing Cooperation Indemnity 7.13(b) Financing Indemnitees 7.13(b) Financing Sources 1.1 Foreign Benefit Plan 1.1 GAAP 5.5(b) Governmental Entity 5.4 Hazardous Materials 1.1 Indemnified Parties 7.6(a) Intellectual Property 1.1 Intervening Event 1.1 IRS 1.1 Knowing and Intentional Breach 1.1 Knowledge 1.1 Law 1.1 Lien 1.1 Mandated Benefit Plan 1.1 Material Contract Section 4.9 5.8(a) Maximum Amount 7.6(b) Merger Recitals Merger Consideration 4.1(c) Minimum Condition 2.1(b) Nasdaq 1.1 Nasdaq Rules 1.1 New Exercise Date 7.8 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)1.1
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Allocated Loan Amount Section 4.4(a1.10(a) Associate Allocated Loan Amounts Section 8.11 1.10(a) Anti-Terrorism Regulations Section 3.20(b) Assessments Section 3.03(a) Assignment Section 1.10(b) Assignments Section 1.10(c) Award Section 3.08(b) Balance Section 1.03(a) Borrower Preamble Borrowers Preamble Business Recitals CFC Day Section 4.17(f1.04(b) Closing CMS Section 3.1 Closing 11.01(a)(ii) CHT Entity Section 5.01 CHT REIT Section 5.01 CON Section 11.01(a)(iii) Control, Controlled or Controlling Section 3.22 Costs Section 4.01 Creditors Rights Laws Section 3.22(y) Cross Collateral Assignment of Leases Section 1.10(d) Cross Collateral Assignments Section 1.10(e) Cross Collateral Documents Section 1.10(f) Cross Collateral Mortgage Section 1.10(g) Cross Collateral Mortgages Section 1.10(h) Daily Charge Section 1.04(a) Damage Section 3.07(a) Debt Service Coverage Ratio Section 3.10 Default Rate Section 1.04(b) Deposits Section 3.10(a) Discount Rate Section 1.06 Documents Section 1.02 Due Date Section 3.1 Code 1.03(c) Environmental Indemnity Section 4.17(f1.10(i) Company Preamble Company Intellectual Environmental Indemnities Section 1.10(j) Environmental Law Section 3.12(a) Environmental Liens Section 3.12(b) Environmental Report Section 3.12(a) ERISA Section 3.11(a) ERISA Indemnity Section 1.10(k) ERISA Indemnities Section 1.10(l) Escrow Agreement Section 1.10(m) Escrow Funds Section 10.04(a) Event of Default Section 6.01 Executive Order 13224 Section 2.09 Exiting Property Section 4.8(a5.03 FF&E Section 3.05(g) Company Owned Intellectual FHA Act Section 2.04(i) First Notice Section 3.15(c) Flood Acts Section 2.04(a) Full Replacement Cost Section 3.06(a) Funding Date Section 1.03(a) Governmental Authority Section 11.01(a)(iv) Grace Period Section 6.01(c) Hazardous Materials Section 3.12(a) Healthcare Laws Section 11.01(a)(v) Healthcare Permit Section 11.01(a)(vi) HIPAA Section 11.01(a)(vii) HIPAA Compliant Section 11.01(a)(viii) Impositions Section 3.10(a) Indemnified Parties Section 8.03 Indemnify Section 8.03 Individual Beneficiaries Section 2.09 Individual Loan Recitals, Section 4 Individual Loan Documents Section 1.02 Individual Property Section 4.8(b1.10(n) Consideration Shares Individual Shareholders Section 2.2 Constitutional Documents 2.09 Insurance Premiums Section 4.4(a3.10(a) Conversion Shares Instrument Section 2.5 Disclosure Schedule 1.10(o) Instruments Section 1.10(p) Investors Section 9.06(a) Late Charge Section 1.04(a) Laws Section 3.05(c) Lender Preamble Lender Affiliates Section 9.10 Lien Section 1.10(q) LLC Agreement Section 3.22(x) Loan Recitals, Section 4 Domestic Company Preamble Equity Losses Section 8.03 Manager Paid Amount Section 10.04(d) Maturity Section 1.03(d) Maturity Date Section 1.03(d) MBA Form Section 3.06(d) Medicaid Section 11.01(a)(ix) Medicare Section 11.01(a)(x) Member Section 3.22(x) Microbial Matter Section 3.12(a) Net Proceeds Section 3.07(d) NOI Section 3.10 Note Section 1.10(r) Notes Section 1.10(s) Note Rate Section 1.03(a) Notice Section 9.02 O&M Plan Section 3.12(b) Obligations Section 1.01 OFAC Section 2.09 OFAC Indemnity Section 8.01(a) OFAC Lists Section 2.09 OFAC Violation Section 3.20(c) Operator Section 1.10(t) Operators Section 1.10(u) Organization State Section 2.01 Owner Section 1.10(v) Owners Section 1.10(w) Owner’s Sole Member Section 2.05 Partial Recourse Guaranty Section 1.10(x) PCBs Section 3.12(a) Permits Section 11.01(a)(xi) Permitted Capital Leases Section 11.02(h) Permitted Encumbrances Section 2.01 Permitted Transfer Section 5.01 Permitted Transfers Section 5.01 Pool Obligations Section 1.10(y) Prepayment Premium Section 1.06 Present Value of the Company Loan Section 2.3(i1.06 Property Section 1.10(z) FCPA Property Payables Section 4.19 HKIAC 3.09 Property State Section 9.17(b2.01 Provider Section 11.02(b)(iii) HK Subsidiary Preamble Indemnitee PSA Section 9.1(a10.04(a) Indemnifiable PTE Section 3.11(a) Rating Agency Section 9.06(a) Recourse Documents Section 1.10(aa) Recourse Guarantor Section 1.10(bb) Recourse Liabilities Guaranty Section 1.10(cc) Recourse Liabilities Guaranties Section 1.10(dd) Recourse Parties Section 8.01 Release Section 3.12(a) Rent Loss Proceeds Section 9.1(a3.07(c) Investor Preamble Investor’s Partners Rent Roll Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) 2.11 Replacement Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC Section 4.18(a) OFAC Sanctions Section 4.18(a) OFAC Sanctioned Person Section 4.18(b) Ordinary Shares Section 2.5 Personal Information Section 4.30 PFIC Section 4.17(g) Public Software Section 4.8(g) Purchased Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f10.04(e) SDN List Replacement Manager Section 4.18(b3.29 Replacement Manager Term Sheet Section 3.29 Resident Agreements Section 11.01(a)(xii) Secretary Restoration Section 4.18(a3.07(a) Series D Investor(sRevenue Code Section 2.05 Second Notice Section 3.15(c) Recitals Series D Preferred Shares Recitals Series D Securities Section 9.06(a) Security Agreement Section 7.01 Senior Living Facility Exhibit B Special Redemption Member Section 8.24 Series D Special Redemption Shareholder 3.22(x) Supplemental Loan Section 8.24 Special Redemption Consideration Shares 5.02(a) TADS Section 8.24 Special Redemption Price 3.10 Taking Section 8.24 Subpart F Income 3.08(a) Tenant Recovery Section 8.17(b3.25 Third Party Payor Section 11.01(a)(xiii) Third Party Payor Programs Section 11.01(a)(xiv) Tranquility Escrow Agreement Section 10.04(f) Tranquility Escrow Funds Section 10.04(f) Transaction Documents Taxes Section 4.4(a3.03(c) UNCITRAL Rules Treasury Rate Section 9.16(b1.06 TRICARE Section 11.01(a)(xv) United States Person Trustee Recitals, Section 4.18(c6 U.C.C. Section 2.02 Violation Section 3.11(c) WFOE Preamble Xunlei Group Section 8.5(bLOAN AGREEMENT THIS LOAN AGREEMENT (this “Agreement”) is made as of the 21st day of December, 2012, by and among CHT Brookridge Heights MI Owner, LLC, a Delaware limited liability company (“CHT Brookridge”), CHT Brookridge Heights MI Tenant Corp., a Delaware corporation (“CHT Brookridge Tenant”), CHT Xxxxx House MI Owner, LLC, a Delaware limited liability company (“CHT Xxxxx”), CHT Xxxxx House MI Tenant Corp., a Delaware corporation (“CHT Xxxxx Tenant”), CHT Symphony Manor MD Owner, LLC, a Delaware limited liability company (“CHT Symphony”), CHT Symphony Manor MD Tenant Corp., a Delaware corporation (“CHT Symphony Tenant”), CHT Tranquility at Fredericktowne MD Owner, LLC, a Delaware limited liability company (“CHT Fredericktowne”), CHT Tranquility at Fredericktowne MD Tenant Corp., a Delaware corporation (“CHT Fredericktowne Tenant”), CHT Woodholme Gardens MD Owner, LLC, a Delaware limited liability company (“CHT Woodholme”), CHT Woodholme Gardens MD Tenant Corp., a Delaware corporation (“CHT Woodholme Tenant”), each having its principal office and place of business as shown on Exhibit E attached hereto (each of the foregoing entities is referred to individually as a “Borrower” and collectively as “Borrowers”), and THE PRUDENTIAL INSURANCE COMPANY OF AMERICA, a New Jersey corporation, having an office at c/o Prudential Asset Resources, Inc., 0000 Xxxx Xxxxxx, Suite 2500, Dallas, Texas 75201, Attention: Asset Management Department; Reference Loan Nos. 706109031-706109035, as lender (“Lender”).
Appears in 1 contract
Agreement Preamble. Ancillary Agreements Alternate Debt Financing Section 4.4(a6.6(b) Associate Bankruptcy and Equity Exception Section 8.11 Business 4.3(a) Buyer Group Contracts Section 5.11 Cashed-Out Option Section 3.1(f)(ii) Cayman Companies Law Recitals CFC Certificates Section 4.17(f3.2(c) Closing Section 3.1 2.2 Closing Date Section 3.1 Code Section 4.17(f) 2.2 Company Preamble Company Adverse Recommendation Change Section 6.4(c)(i) Company Board Recitals Company Financial Advisor Section 4.3(b) Company Financial Statements Section 4.6(b) Company Group Section 8.2(e)(i) Company Intellectual Property Rights Section 4.8(a4.14(a) Company Owned Intellectual Property Section 4.8(b) Consideration Shares Section 2.2 Constitutional Documents Section 4.4(a) Conversion Shares Section 2.5 Disclosure Schedule Section 4 Domestic Company Preamble Equity Value of the Company Section 2.3(i) FCPA Section 4.19 HKIAC Section 9.17(b) HK Subsidiary Preamble Indemnitee Section 9.1(a) Indemnifiable Loss Section 9.1(a) Investor Preamble Investor’s Partners Section 8.17(b) Key Employee Section 4.22 Key Holders Preamble Lease Section 4.7(b) Licenses Section 4.8(e) Management Founder Preamble Management Founder Holdco Preamble Market Capitalization of Xunlei Section 2.3(ii) Material Adverse Effect Section 4.1 Material Contract Section 4.9 OFAC 4.11(a) Company Plans Section 4.18(a4.9(a) OFAC Sanctions Company Recommendation Section 4.18(a4.3(b) OFAC Sanctioned Person Company Representatives Section 4.18(b6.3(a) Ordinary Company SEC Filings Section 4.6(a) Company Shareholders Meeting Section 6.2(b)(i) Company Subsidiary Section 4.1 Company Termination Fee Section 8.2(b) D&O Insurance Section 6.12(c) Debt Financing Section 5.6(a) Debt Financing Agreements Section 6.6(b) Debt Financing Commitments Section 5.6(a) Dissenter Rights Section 3.1(e) Dissenting Shares Section 2.5 Personal Information 3.1(e) Dissenting Shareholders Section 4.30 PFIC 3.1(e) Effective Time Section 4.17(g2.3 Equity Financing Section 5.6(a) Public Equity Financing Commitments Section 5.6(a) End Date Section 8.1(b)(i) Exchange Fund Section 3.2(b) Fee Letter Section 5.6(a) Financing Section 5.6(a) Financing Agreements Section 6.6(a) Financing Commitments Section 5.6(a) Founder Securityholders Preamble Global Village Preamble HKIAC Section 9.7(c) Holdco Preamble Indemnified Parties Section 6.12(a) Investments Section 4.2(d) Leased Real Property Section 4.17(b) Limited Guarantee Recitals Merger Recitals Merger Consideration Section 5.6(b) Merger Sub Preamble Midco Preamble New Debt Financing Commitment Section 6.6(b) Notice Period Section 6.4(d)(iii) Open Source Software Section 4.8(g4.14(d) Purchased Option Consideration Section 3.1(f)(ii) Outstanding Proposal Section 8.2(b)(iii) Owned Real Property Section 4.17(a) Parent Preamble Parent Group Section 8.2(e)(i) Parent Party Preamble Parent Representatives Section 6.3(a) Parent Termination Fee Section 8.2(c) Party Preamble Paying Agent Section 3.2(a) Per ADS Merger Consideration Section 3.1(b) Per Share Merger Consideration Section 3.1(b) Plan of Merger Section 2.3 Proxy Statement Section 6.2(a) Registrar of Companies Section 2.3 SAFE Rules and Regulations Section 4.5(b) Schedule 13E-3 Section 4.4(b) Special Committee Recitals Surviving Company Section 2.1 Transaction Litigation Section 6.8 Uncertificated Shares Section 2.1 Restriction Period Section 8.11 Restricted Share Agreement Section 6.1(f3.2(c) SDN List Section 4.18(b) Secretary Section 4.18(a) Series D Investor(s) Recitals Series D Preferred Shares Recitals Series D Special Redemption Section 8.24 Series D Special Redemption Shareholder Section 8.24 Special Redemption Consideration Shares Section 8.24 Special Redemption Price Section 8.24 Subpart F Income Section 8.17(b) Transaction Documents Section 4.4(a) UNCITRAL Rules Section 9.16(b) United States Person Section 4.18(c) WFOE Preamble Xunlei Group Section 8.5(b)Young Vision Preamble
Appears in 1 contract
Samples: Agreement and Plan of Merger (Qihoo 360 Technology Co LTD)
